InvestorBrandNetwork (IBN) Content Platform

October 30, 2023 13:35:00

Sekur Private Data has reported increasing new subscriber signups for SekurVPN, the world’s first non-big-tech-powered, Swiss-hosted privacy-focused VPN solution launched in April
So far, SekurVPN’s sales have surpassed its projections, and the company is now expecting solid growth for SekurVPN for the foreseeable future
The company recently announced plans to increase its prices for SekurVPN by 30%, following careful considerations and consultations with the digital marketing team
Even with the new prices, SekurVPN is still the most affordable privacy VPN in the market, according to CEO Alain Ghiai
Sekur Private Data recently announced plans to launch its Swiss-hosted communications suite, Sekur, in the German language and launch a digital marketing campaign in the DACH region

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FRA: GTD0), a global leader in Swiss-hosted secure data management and communication solutions, has consistently endeavored to prioritize requests from its existing and would-be customers, launching products and solutions that cater to customers’ professed needs. Earlier this year, the company launched SekurVPN, the world’s first non-big-tech-powered, Swiss-hosted privacy-focused VPN solution (https://ibn.fm/vbLx6).

“We are excited to announce the launch of SekurVPN. The idea got prioritized as we received numerous requests from our existing and would-be customers through our support platform, and our efforts have culminated in this timely launch,” Sekur Private Data CEO Alain Ghiai said at the…

NOTE TO INVESTORS: The latest news and updates relating to SWISF are available in the company’s newsroom at https://ibn.fm/SWISF

About TechMediaWire

TechMediaWire (“TMW”) is a specialized communications platform with a focus on pioneering public and private companies driving the future of technology. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, TMW brings its clients unparalleled recognition and brand awareness. TMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from TechMediaWire, text “TECH” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Los Angeles, CA
www.TechMediaWire.com
310.299.1717 Office
[email protected]

TechMediaWire is powered by IBN

GreenEnergyBreaks – Power Hero Corporation, Arrow Electronics Formalize Strategic Alliance

October 30, 2023 11:58:46

Power Hero Corp. today announced that it has strengthened its collaboration with Arrow Electronics. “Our business ethos is centered around spearheading the conceptual design of revolutionary power charging solutions for the electric vehicle (‘EV’) industry. Through this strategic alliance with Arrow Electronics, we tap into their unparalleled engineering acumen and manufacturing proficiency to create innovative, high-quality products for a rapidly growing market,” said Rob Kent, Power Hero’s co-founder. “We are pleased therefore to sign a master services agreement and design contract with eInfochips, a dynamic wholly owned subsidiary and design arm of the Arrow Company.”

To view the full press release, visit https://ibn.fm/zAda3

About Power Hero

Power Hero stands at the forefront of innovation, championing unique EV charging solutions for the vast global populace dwelling within multi-unit residential buildings (“MURBs”). Boasting an impressive array of patented offerings with 167 patent claims granted, Power Hero’s product portfolio is engineered to leverage pre-existing electrical infrastructure and power access points. This ingenuity enables the provision of personal Level 2 rapid charging, allowing all drivers to avoid waiting in line at public stations. Essentially granting MURB residents the luxury of dedicated “home” charging.

About GreenEnergyStocks

GreenEnergyStocks (“GES”) is a specialized communications platform with a focus on companies working to shape the future of the green economy. GreenEnergyStocks is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, GES is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, GES brings its clients unparalleled recognition and brand awareness. GES is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from GreenEnergyStocks, text “Green” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenEnergyStocks.com

Please see full terms of use and disclaimers on the GreenEnergyStocks website applicable to all content provided by GES, wherever published or re-published: https://www.greennrgstocks.com/Disclaimer

GreenEnergyStocks
Los Angeles, CA
www.GreenEnergyStocks.com
310.299.1717 Office
[email protected]

GreenEnergyStocks is powered by IBN

InvestorNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Extends Collaboration with Romanian Government on Pivotal EM Initiative

October 30, 2023 11:49:55

SuperCom Ltd. (NASDAQ: SPCB), a global provider of secured solutions for the e-Government, IoT and cybersecurity sectors, today announced, together with its local partner, the receipt of a third order by Romania’s Ministry of Interior, further extending the successful partnership and reinforcing their commitment to Romania’s National Electronic Monitoring (“EM”) Project. According to the announcement, the order is valued at approximately $3.4 million and is anticipated to be delivered by the end of the fourth quarter of 2023. “We are excited to extend our collaboration with the Romanian government on this pivotal initiative. The recent order, valued at $3.4 million, underscores the caliber of our technology and the unwavering trust our clients have in SuperCom,” said Ordan Trabelsi, president and CEO of SuperCom. “The Romanian Project is progressing as planned. Thanks to our expert team and state-of-the-art technology, we’ve ensured flawless execution, consistently meeting and surpassing stakeholder expectations. This latest order reinforces our status as a global frontrunner in electronic monitoring solutions. At SuperCom, we are dedicated to not only achieving excellent outcomes but also building enduring relationships with governments across the globe.”

To view the full press release, visit https://ibn.fm/Shqvj

About SuperCom

Since 1988, SuperCom has been a global provider of traditional and digital identity solutions, providing advanced safety, identification and security solutions to governments and organizations, both private and public, throughout the world. Through its proprietary e-Government platforms and innovative solutions for traditional and biometrics enrollment, personalization, issuance and border control services, SuperCom has inspired governments and national agencies to design and issue secure multi-ID documents and robust digital identity solutions to its citizens and visitors. SuperCom offers a unique all-in-one field-proven RFID & mobile technology and product suite, accompanied by advanced complementary services for various industries including healthcare and homecare, security and safety, community public safety, law enforcement, electronic monitoring, livestock monitoring, and building and access automation. For more information about the company, visit www.Supercom.com.

NOTE TO INVESTORS: The latest news and updates relating to SPCB are available in the company’s newsroom at http://ibn.fm/SPCB

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Reports on 1-for-17 Reverse Stock Split

October 30, 2023 11:24:56

PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company focusing on the development of novel anti-purinergic drug therapies (“APT”) for the treatment of autism spectrum disorder (“ASD”) and other serious conditions with intractable neurologic symptoms, has released information regarding its 1-for-17 reverse stock split. According to the announcement, as a result of the reverse stock split of PaxMedica’s common stock that became effective at 8:03 a.m. ET today, the company’s common stock will begin trading on a split-adjusted basis tomorrow, Oct. 31, 2023, when the market opens. The company noted that its common stock will continue to trade under the existing trading symbol PXMD. “As a result of the reverse stock split, each 17 presplit shares of common stock outstanding were automatically combined and converted into one issued and outstanding share of common stock,” the company stated in the press release. “No fractional shares of common stock were issued to any stockholders in connection with the reverse stock split. Holders of record who would otherwise have been entitled to receive a fractional share received a number of shares rounded up to the next whole share in lieu of fractional shares.”

To view the full press release, visit https://ibn.fm/iIYGS

About PaxMedica Inc.

PaxMedica is a clinical-stage biopharmaceutical company focusing on the development of anti-purinergic drug therapies (“APT”) for the treatment of disorders with intractable neurologic symptoms, ranging from neurodevelopmental disorders, including autism spectrum disorder (“ASD”) to myalgic encephalomyelitis/chronic fatigue syndrome (“ME/CFS”), a debilitating physical and cognitive disorder. One of PaxMedica’s primary points of focus is the development and testing of its lead program, PAX-101, an intravenous formulation of suramin, in the treatment of ASD and the advancing the clinical understanding of using that agent against other disorders such as ME/CFS. For more information about the company, visit www.PaxMedica.com.

NOTE TO INVESTORS: The latest news and updates relating to PXMD are available in the company’s newsroom at https://ibn.fm/PXMD

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed)and Life Sciences sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

MiningNewsBreaks – Resourcing Tomorrow Announces Inaugural Roundtable, Reception to Focus on Critical Mineral Strategies

October 30, 2023 11:10:48

Resourcing Tomorrow, Europe’s largest mining event, has announced plans to hold its first Critical Minerals Ministerial Roundtable and Reception next month, in conjunction with the Critical Minerals Association and hosted by the UK All-Party Parliamentary Groups (“APPG”). According to the announcement, representatives from numerous countries will be attending, including Australia, Armenia, Canada, Chad, Nigeria, the Kingdom of Saudi Arabia, the Kyrgyz Republic, the Czech Republic, Portugal, the United Kingdom and the United States. The Resourcing Tomorrow event is slated for Nov. 28–30, 2023, with the roundtable and reception scheduled on Nov. 27, one day before the main event kicks off. According to the announcement, the world is at a key juncture as countries work to transition to greener energy with each resource-rich country facing unique pressure to attract lasting, meaningful investment into the development of their respective critical mineral resources.

A robust critical minerals policy is essential to creating a stable landscape for investors as well as benefitting the local population and country as a whole. “The U.S. Inflation Reduction Act is game changer, providing $783 billion of investment, much of it will flow into investments into not just U.S. -based mining projects but mining projects with countries aligned with Western thinking,” said Resourcing Tomorrow divisional director Andrew Thake in the press release. “At least 40% of critical minerals in U.S.-made EV batteries must come U.S. miners or recycling plants, or mines in countries with free trade deals with the U.S.”

To view the full press release, visit https://ibn.fm/4aGhy

About Resourcing Tomorrow

Resourcing Tomorrow represents an incomparable opportunity for all those seeking engagement in the mining sector. Europe’s largest mining event, Resourcing Tomorrow focuses on accelerating the energy transition. The event will examine the current and future economic and social dependence on resources, considering issues such as critical minerals supply, environmental resilience, digitalization, the circular economy, ESG and the future workforce. Mining and resources have been a remarkable source of wealth and progression. With that, comes significant responsibility. Resourcing Tomorrow represents an unparalleled opportunity for all organizations seeking engagement with mining, energy and resources. For more information about this company, please visit www.ResourcingTomorrow.com.

About MiningNewsWire

MiningNewsWire (“MNW”) is a specialized communications platform with a focus on developments and opportunities in the Global Mining and Resources sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled recognition and brand awareness.

MNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from MiningNewsWire, text “BigHole” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, CA
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is powered by IBN

DEF Files Amicus Brief Supporting Crypto Users’ Rights

October 30, 2023 11:05:00

A crypto advocacy organization, the DeFi Education Fund, has requested a U.S. court consider the distinct blockchain technology characteristics when assessing the Fourth Amendment rights of privacy for crypto users. The fund formally submitted an amicus brief to the appeals court on Oct. 20, 2023, in favor of James Harper’s case against the IRS. The petition is part of a campaign to thwart the government’s unfettered access to cryptocurrency platform users’ transaction records.

Harper was one of 14,355 Coinbase users whose information was disclosed to the IRS in 2017, leading to…

About CryptoCurrencyWire

CryptoCurrencyWire (“CCW”) is a specialized communications platform with a focus on blockchain and the cryptocurrency sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CCW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CCW brings its clients unparalleled recognition and brand awareness. CCW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CryptoCurrencyWire, text “CRYPTO” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.CryptoCurrencyWire.com

Please see full terms of use and disclaimers on the CryptoCurrencyWire website applicable to all content provided by CCW, wherever published or re-published: https://www.CryptoCurrencyWire.com/Disclaimer

CryptoCurrencyWire
New York, NY
www.CryptoCurrencyWire.com
212.994.9818 Office
[email protected]

CryptoCurrencyWire is powered by IBN

DEF Files Amicus Brief Supporting Crypto Users’ Rights

October 30, 2023 11:05:00

Harper was one of 14,355 Coinbase users whose information was disclosed to the IRS in 2017, leading to a fervent push for more robust rights and protection of digital privacy.

The core mission of the DeFi Education Fund is to promote regulatory clarity within the DeFi ecosystem and to educate policymakers about the advantages of DeFi. It seeks to create an atmosphere that promotes innovation while guaranteeing the protection of user privacy and rights.

DEF stated that it was honored to support the industry by providing amicus briefs in instances that set precedents, such as Harper vs. IRS, which involved a John Doe subpoena to Coinbase and resulted in the IRS obtaining the personal financial information of more than 14,300 customers. According to DEF, it is critical that the amendment be reexamined in order to achieve an equilibrium between the investigative powers of law enforcement and a person’s right to preserve their financial privacy in the digital era. The amendment serves as a safeguard against unwarranted government seizures and searches.

Additionally, DEF used Carpenter vs. U.S. to support its claim that the amendment aims to limit the government’s access to data obtained through third-party entities. The group further elucidated that actual users can be connected to pseudonymous addresses since crypto transactions are traceable on public ledgers.

This had profound implications for the lives and privacy of Coinbase users and the case as well. According to DEF, the federal government’s request effectively implicated every transaction a user has ever made — past, present and future — revealing their personal as well as their political, religious and familial ties. DEF further stressed that the amount of knowledge gleaned from this data is much beyond that which could be obtained from conventional banking records.

The ultimate verdict in the case of Harper vs. Werfel and the IRS is poised to establish a significant precedent concerning digital privacy rights and law-enforcement measures within the United States.

Pioneering companies such as HIVE Blockchain Technologies Ltd. (NASDAQ: HIVE) (TSX.V: HIVE) hope that the outcome of these cases don’t set precedents that stifle the growth of the crypto industry.

About CryptoCurrencyWire

To receive SMS alerts from CryptoCurrencyWire, text “CRYPTO” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.CryptoCurrencyWire.com

CryptoCurrencyWire
New York, NY
www.CryptoCurrencyWire.com
212.994.9818 Office
[email protected]

CryptoCurrencyWire is powered by IBN

Study Suggests Methamphetamine More Helpful for Social Bonding Compared to MDMA

October 30, 2023 10:56:50

A recent study on methamphetamines and MDMA has produced interesting findings on the two drugs and their potential association with human connection. Researchers found that both MDMA and methamphetamines can enhance feelings of closeness and connectedness, but methamphetamines seemed to deliver stronger long-term benefits on social bonding compared to the psychedelic.

While both methamphetamines and MDMA are psychoactive in nature, they affect people in wildly different ways. MDMA (also known as molly or ecstasy) is a hallucinogenic with…

NOTE TO INVESTORS: The latest news and updates relating to Lucy Scientific Discovery Inc. (NASDAQ: LSDI) are available in the company’s newsroom at https://ibn.fm/LSDI

About PsychedelicNewsWire

PsychedelicNewsWire (“PNW”) is a specialized communications platform with a focus on all aspects of psychedelics and the latest developments and advances in the psychedelics sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, PNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, PNW brings its clients unparalleled recognition and brand awareness. PNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from PsychedelicNewsWire, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

PsychedelicNewsWire
San Francisco, CA
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]

PsychedelicNewsWire is powered by IBN

How Junior Mining Firms Can Leverage Current Market Conditions

October 30, 2023 10:50:23

The junior mining segment has had a rough couple of years, experiencing two years straight of lackluster returns and a losing streak that rivals the segment’s historic gold bear market in from 2011 to 2015. This year has been just as difficult for junior miners as most players in the sector have seen another year of poor performance amid record underinvestment.

Investment in the mining sector has been declining for the past decade, and the junior mining sector has felt it the most. Smaller companies typically have…

NOTE TO INVESTORS: The latest news and updates relating to Eloro Resources Ltd. (TSX: ELO) (OTCQX: ELRRF) are available in the company’s newsroom at http://ibn.fm/ELRRF

About MiningNewsWire

MNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from MiningNewsWire, text “BigHole” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, CA
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is powered by IBN

Companies Race to Develop Battery Testing Tech to Assess Used EVs

October 30, 2023 10:44:34

Companies are racing to develop technology for certifying the health and performance of used electric vehicle batteries. More than a decade after Tesla popularized mass-market electric cars, the secondhand electric vehicle market is growing larger by the year.

Most initial adopters have already traded in their old EV models for newer ones, and as the market matures and sales increase, we can expect the market for…

About GreenCarStocks

GreenCarStocks (“GCS”) is a specialized communications platform with a focus on electric vehicles (“EVs”) and the green energy sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled recognition and brand awareness. GCS is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from GreenCarStocks, text “Green” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the GreenCarStocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

GreenCarStocks
Los Angeles, CA
www.GreenCarStocks.com
310.299.1717 Office
[email protected]

GreenCarStocks is powered by IBN

Study Identifies Immune Cells Responsible for Severe Asthma

October 30, 2023 10:39:07

Researchers from the University of Southampton, United Kingdom and La Jolla Institute for Immunology (LJI) have identified a group of immune cells that may be responsible for severe asthma. Identified as cytotoxic CD4+ tissue-resident memory T cells, these cells congregate in the lungs and seem to have the ability to cause the harm associated with later development of asthma.

Researchers say these immune cells are especially prevalent in men and note that men who are diagnosed with asthma after age 40 often have high counts of…

NOTE TO INVESTORS: The latest news and updates relating to Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) are available in the company’s newsroom at https://ibn.fm/SCNI

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

BioMedNewsBreaks – Safety Shot Inc. (NASDAQ: SHOT) Announces Planned Launch of Its Highly Anticipated Wellness Beverage

October 30, 2023 10:34:55

Safety Shot (NASDAQ: SHOT) today announced the upcoming direct-to-consumer launch of Safety Shot, the first patented beverage on Earth that helps people feel better faster by reducing blood alcohol content and boosting clarity. Beginning the first week of December 2023, the beverage will be available for retail purchase at www.DrinkSafetyShot.com and www.Amazon.com. In addition, the company plans to launch business-to-business sales of Safety Shot to distributors, retailers, restaurants and bars in the first quarter of 2024. “We’re very excited to launch Safety Shot through our multichannel strategy designed to dominate e-commerce, quickly win retail shelf space, and establish longstanding ties with key distribution and sales partners,” said Safety Shot’s CEO Brian John. “Led by our executive managed team that has launched numerous successful brands and business and led sales into the billions at companies including Anheuser Busch, and supported Advantage Solutions as well as our growing roster of brand ambassador influencers, we are confident that Safety Shot will become a blockbuster product creating a new category in the beverage industry.”

To view the full press release, visit https://ibn.fm/lWP0A

About Safety Shot Inc.

Safety Shot, a wellness and functional beverage company, is set to launch Safety Shot, the first patented beverage on Earth that helps people feel better faster by reducing blood alcohol content and boosting clarity. The company plans to spin off legacy assets from its Jupiter Wellness business to unlock value for shareholders.

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

InvestorNewsBreaks – PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTC: PLTXF) Announces Addition of Meek’s Vegan Pizza to Chicago Foodhall Offerings

October 30, 2023 10:24:24

PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTC: PLTXF), the digital face of the plant-based community operating a one-stop shop for plant-based products, is adding another well-known vendor to its Chicago Foodhall lineup. Meek’s Vegan Kitchen, which has gained a reputation for its Famous Vegan Pizza with origins in Houston, Texas, is set to capture the attention of plant-based pizza enthusiasts in Chicago. A celebrated Black-owned establishment, Meek’s Vegan Kitchen creates exquisite flavors and follows cruelty-free practices. The company was conceptualized by Demetrius Walker, who was looking for a vegan pizza his son would like. Ultimately, Walker was joined by friend and fellow culinary visionary Antonio “Tone” Barnes, who brought together a group of entrepreneurs to form MAKAS Management; others on the team include Allen Slovick, Gregory Henderson Jr, and Keith Johnson. As a result, Meek’s Vegan Kitchen opened in February 2023. Meek’s Vegan Kitchen will replace Kitchen 17’s Station 17:B kiosk, which has been in the foodhall.

According to the announcement, after a month of operations, PlantX realized that partnering with restaurants looking to run their own restaurant operations is the ideal approach for the innovative foodhall setting. “After my first call with Tone and the entire team behind Meek’s, I was just so blown away by the grit and hustle, and I knew they needed to be a part of what we’re doing here,” said PlantX Life founder Sean Dollinger in the press release. “I would also like to give a shoutout to Joe and Jennie from Kitchen 17. They have been amazing partners since day one, and I know their wholesale business is going to thrive. I cannot wait to see sales for their frozen pizzas online and in our bodega. This transition marks an exciting chapter in PlantX’s journey to redefine plant-based dining, and we look forward to the continued support of our dedicated patrons and the warm embrace of Meek’s Vegan Pizza.”

To view the full press release, visit https://ibn.fm/1ppAH

About PlantX Life Inc.

PlantX is committed to being the digital face of the plant-based community as well as the one-stop shop for plant-based products. With its fast-growing category verticals, the company offers customers across North America more than 5,000 plant-based products. PlantX also has other brands in the PlantX portfolio, including a juice brand, a coffee company, a plant shop and brick-and-mortar grocery stores. PlantX uses its digital platform to build a community of like-minded consumers and, most importantly, to provide education. PlantX’s digital presence eliminates entry barriers for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life. For more information about this company, please visit www.PlantX.com and www.PlantX.ca.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Mountain Top Properties Inc. (MTPP) Is ‘One to Watch’

October 30, 2023 10:20:00

Mountain Top Properties has issued 250,108,363 shares of common stock as of August 2023
The company will consider selling securities to fund future operations
Mountain Top Capital Fund I has a target to raise $75 million to fund its Hamptons projects
The company targets minimum ROI of 20% to 30% per transaction

Mountain Top Properties (OTC: MTPP) is a diversified real estate holding company that acquires, sells and operates assets through its wholly owned subsidiaries and limited partnerships. The company specializes in property management, property technology (“PropTech”) and real estate redevelopment.

Mountain Top Properties was incorporated in 1990 and is based in Liverpool, New York, with offices in…

NOTE TO INVESTORS: The latest news and updates relating to MTPP are available in the company’s newsroom a https://ibn.fm/MTPP

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces Participation at BIO-Europe Munich 2023

October 30, 2023 09:45:02

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative inflammation and immunology (“I&I”) biological products primarily for the treatment of autoimmune and infectious diseases, will be attending and participating in BIO-Europe, one of Europe’s premier pharmaceutical industry partnering events. The event is slated for Nov. 6–8, 2023, in Munich, Germany. According to the announcement, Scinai will showcase both its CDMO services, marketed under the brand Scinai Bioservices, and its in-house nanosized VHH antibody-based therapeutics pipeline. In addition, management will be available to meet with potential partners and clients. Scinai offers a state-of-the-art manufacturing facility for biopharmaceutical products as well as biologic drugs process development and scale-up for protein-based drugs; the company also provides analytical method development for QC testing and cGMP manufacturing. In addition, the company’s in-house R&D program specializes in developing, manufacturing and commercializing I&I biological products targeting the treatment of autoimmune and infectious diseases.

To view the full press release, visit https://ibn.fm/0Hzwi

About Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative inflammation and immunology (“I&I”) biological products primarily for the treatment of autoimmune and infectious diseases. With a state-of-the-art facility for biopharmaceutical product development and manufacturing along with highly experienced pharmaceutical industry leadership, Scinai offers end-to-end boutique CDMO services in parallel to developing its own pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized VHH antibody, or NanoAb, pipeline targeting diseases with large unmet medical needs. For more information, visit the company’s website at www.Scinai.com.

NOTE TO INVESTORS: The latest news and updates relating to SCNI are available in the company’s newsroom at https://ibn.fm/SCNI

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

SenesTech Inc. (NASDAQ: SNES) Geometrically Increases its Addressable Market with the Addition of Evolve(TM) Soft Bait to its Portfolio

October 30, 2023 09:35:00

SenesTech, a rodent fertility control expert, just announced the launch of its Evolve(TM) Soft Bait, representing an innovative, patent pending, minimum risk alternative treatment to reduce fertility in rats
This product adds to the company’s growing line of pest control solutions, such as ContraPest(R), a highly palatable liquid contraceptive bait
SenesTech’s management has lauded this milestone, noting how the product, with its non-liquid form, will dramatically increase its addressable market
The company plans to market it to professionals as well as directly to consumers through e-commerce and big-box stores

SenesTech (NASDAQ: SNES), a rodent fertility control expert and the inventor of the only EPA-registered contraceptive for male and female rats, just announced the launch of its Evolve(TM) Soft Bait (“Evolve”), a minimum-risk solution in a new form, designed to reduce fertility in rats. As a potential solution to the root cause of pest problems – rats’ ability to rapidly reproduce – Evolve offers an effective product in a format that is familiar to pest control professionals and at a price that is comparable to traditional rodenticides. Results can be seen in as little as four to six weeks (https://ibn.fm/yS388).

Evolve(TM) adds to SenesTech’s growing line of pest control solutions, such as ContraPest(R), a highly palatable liquid rat contraceptive bait. Like the company’s other products, Evolve(TM) promises to offer a long-term solution to pest problems, effective fertility control, and a user-friendly format perfect for…

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Releases Update on Q3 Production

October 30, 2023 09:16:26

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) today announced that production for the third quarter of 2023 was 38,600 gold equivalent ounces (“GEOs”) and 104,800 GEOs for the nine months ended September 30, 2023. The company maintains its consolidated guidance for 2023 despite the Gold Bar Mine’s production forecast being 13% below its range. McEwen Mining’s forecast for the full year 2023, as detailed in the announcement, reflects actual productions to September 30 and management’s current estimates for the fourth quarter of 2023. Among the highlights, the company reported good progress at its Gold Bar Mine, recovering from a challenging first half of the year, good performance for Fox Complex, and San José production meeting performance expectations. The company further announced that McEwen Copper is now well financed for the remainder of 2023 and well into 2024, with the funds to be used to advance the feasibility study on the Los Azules project and for other corporate purposes.

To view the full press release, visit https://ibn.fm/yQGgJ

About McEwen Mining Inc.

McEwen Mining is a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina. In addition, it owns approximately 47.7% of McEwen Copper, which owns the large, advanced-stage Los Azules copper project in Argentina. The company’s goal is to improve the productivity and life of its assets with the objective of increasing its share price and providing a yield. Its chairman and chief owner has personally provided the company with $220 million and takes an annual salary of $1. For more information about the company, visit www.McEwenMining.com.

NOTE TO INVESTORS: The latest news and updates relating to MUX are available in the company’s newsroom at http://ibn.fm/MUX

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Plans to Release Q3 2023 Financial Results

October 30, 2023 09:07:59

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, will be releasing its financial results for Q3 2023 on Nov. 2, 2023, before the market opens. In addition, the company also announced plans to host a conference call and webcast the same day at 8:30 a.m. ET. According to the announcement, DarioHealth CEO Erez Raphael and president Rick Anderson will host the call. Those wanting to access the call can dial 1-888-886-7786 (domestic) or 1-416-764-8658 (international). An operator will provide assistance, or callers can click on the Call Me(TM) link to access the event. A replay of the call and webcast will be available following the event; that replay can be accessed by dialing 1-844-512-2921 (domestic) or 1-412-317-6671 (international) and using the passcode 68054211.

To view the webcast event, visit https://ibn.fm/qNu2S

To view the full press release, visit https://ibn.fm/LIVa1

About DarioHealth Corp.

DarioHealth Corp. is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric, multichronic condition digital therapeutics platform. Dario’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. The company’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results, and making the right thing to do the easy thing to do. Dario provides its highly user-rated solutions globally to health plans and other payors, self-insured employers and providers of care as well as directly to consumers. For more information about the company, please visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Clene Inc. (NASDAQ: CLNN) Reports Improved Survival Status in ALS Patients Treated with CNM-Au8(R) on Follow-Up Analysis; Announces Peer-Reviewed Study

October 30, 2023 08:50:00

Clene is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases like ALS
In 2019, Clene’s drug candidate, CNM-Au8(R), was selected for the HEALEY ALS Platform Trial, with enrollment commencing in the summer of 2020
Over the years since, Clene has consistently released additional data from the Trial, most recently reporting significant long-term survival improvement among patients treated with CNM-Au8 compared to PRO-ACT historical controls
The company also announced the publication of a peer-reviewed study in the nanotechnology-focused journal Small; the study describes CNM-Au8’s mechanism of action
Clene received a $45.1 million NINDS grant to support an Expanded Access Protocol (“EAP”) program and study for CNM-Au8 in ALS

Amyotrophic lateral sclerosis (“ALS”), or Lou Gehrig’s disease, is a progressive and degenerative neuromuscular disease that destroys nerve cells known as motor neurons, which control voluntary muscle movement (https://ibn.fm/bgJGu). A fatal neurological disorder, ALS lowers the life expectancy of patients to two to five years post-diagnosis, although some patients may live longer, as was the case with the late Stephen Hawking, who lived with ALS for more than five decades (https://ibn.fm/v6LIz).

The Centers for Disease Control and Prevention (“CDC”) estimated that more than 31,000 patients were living with ALS in 2017 (https://ibn.fm/Vdee8), with a subsequent study calculating the 2017 prevalence of ALS in the adult U.S. population arriving at an age-adjusted prevalence of between 5.5 and 9.9 per…

NOTE TO INVESTORS: The latest news and updates relating to CLNN are available in the company’s newsroom at https://ibn.fm/CLNN

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

Longeveron Inc. (NASDAQ: LGVN) Validates Safety and Therapeutic Potential of its Lomecel-B(TM) Lead Investigational Product in its CLEAR MIND Phase 2a Clinical Trial

October 30, 2023 08:05:00

Longeveron, a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions, reported positive top-line results from its CLEAR MIND Phase 2a human clinical trial
The study, which explored Lomecel-B(TM)’s effects on mild Alzheimer’s disease, met the primary endpoint of safety on statistical and medical assessment

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions, just announced positive top-line results from its CLEAR MIND Phase 2a clinical trial for treating mild Alzheimer’s disease. Most notably, the primary endpoint of safety was met based on statistical and medical assessment, with only one Serious Adverse Event (“SAE”) reported on each Lomecel-B(TM) group in what Dr. Jeffrey Cummings, MD, Vice Chair of Research, UNLV Department of Brain Health, described as “Encouraging results” (https://ibn.fm/BNOjU).

This study was designed to explore Lomecel-B(TM)’s effects on mild Alzheimer’s disease. Dubbed the CLEAR MIND trial, this randomized, double-blinded, placebo-controlled Phase 2a trial included 50 patients aged between 60 and 85 years diagnosed with mild Alzheimer’s disease. The study was…

NOTE TO INVESTORS: The latest news and updates relating to LGVN are available in the company’s newsroom at http://ibn.fm/LGVN

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

Can Diabetes, Weight-Loss Drugs Get Even Better?

October 30, 2023 08:05:00

NetworkNewsWire Editorial Coverage: The prestigious New England Journal of Medicine recently published results of a large study of 2,539 adults wherein weight loss of 49 to 52 pounds was a common outcome. With more than 37 million Americans suffering from diabetes, and with obesity at epidemic levels, it’s little wonder that millions of people are singing their praises of the new class of drugs responsible for these outrageously positive outcomes. GLP-1 agonists are a class of medications that mainly help manage blood sugar (glucose) levels in people with type 2 diabetes but are also helping treat obesity. Seems everyone is excited about controlling blood sugar and easily losing weight. But there may be an even better avenue to increased effectiveness and better outcomes. Lexaria Bioscience Corp. (NASDAQ: LEXX) (Profile), a global innovator in drug-delivery platforms, began diabetes-related formal studies last year with its DehydraTECH(TM) platform, which showed reduced blood-sugar levels and lowered body weight. With such encouraging early results, Lexaria is planning to launch new human and animal studies to examine whether DehydraTECH processing can make GLP-1 drugs such as semaglutide even better. Lexaria’s heavily-patented DehydraTECH drug delivery technology might improve bioavailability, lower costs, and enhance tolerability, weight-loss potential and management of diabetes and other health conditions. DehydraTECH may become a game changer in the multibillion-dollar GLP-1 drug market and could potentially lead to a collaboration with a dominant player in the space, such as Novo Nordisk (NYSE: NVO), Pfizer Inc. (NYSE: PFE), Merck & Company Inc. (NYSE: MRK), or AstraZeneca PLC (NASDAQ: AZN).

420 with CNW — Cannabis Regulators Find Retail Outlets Have 99% Compliance Regarding Checking Age

October 30, 2023 03:25:00

A recent investigation by Colorado marijuana regulators has found that 99% of state-legal cannabis stores were compliant with underage sales checks. Out of 285 checks, cannabis regulators found only four failures, representing a “very high” compliance rate of around 99% for 2023.

The state Department of Revenue’s Marijuana Enforcement Division (MED) noted in its latest quarterly Weeds newsletter that while any failure is…

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is powered by IBN

420 with CNW — Lessons for Ohio from Michigan’s Recreational Cannabis Launch

October 27, 2023 15:25:00

Ohio may soon be the latest state in America to legalize recreational cannabis. Reform activists collected enough signatures for a legalization initiative titled Issue 2, and Ohioans are on track to vote on the measure in November.

Multiple polls have found that most Ohio residents plan to vote in favor of the initiative to legalize and regulate recreational cannabis in the…

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is powered by IBN

MiningNewsBreaks – Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) (FSE: A0I0) Completes High-Definition Survey over PCH Ionic Clay Target IV Project Area

October 27, 2023 13:43:24

Appia (CSE: API) (OTCQX: APAAF) (FSE: A0I0) today announced that it has completed a high-definition lidar and orthophoto survey across an area of 1,702.50 hectares, which includes the company’s priority Ionic Clay Target IV project area in Goias, Brazil. Metro Cúbico Engenharia LTDA, which is headquartered in São Paulo and made up of a multidisciplinary team of professionals with more than 20 years of experience in various technological areas, was engaged by Appia to complete the survey. “Orthophotos are essential for the efficient management of our drill campaign as they provide high-resolution and accurate visual information with maximum detail,” said Fabricio Santos, Appia’s geophysics and processes manager. “Furthermore, LiDAR surveying provides a highly accurate contribution to terrain modeling, which is essential to ensure the accuracy of the geological model.”

To view the full press release, visit https://ibn.fm/gtq0d

About Appia Rare Earths & Uranium Corp

Appia is a publicly traded Canadian company in the rare earth element and uranium sectors. The company is currently focusing on delineating high-grade critical rare earth elements and gallium on the Alces Lake property, as well as exploring for high-grade uranium in the prolific Athabasca Basin on its Otherside, Loranger, North Wollaston, and Eastside properties. The company holds the surface rights to exploration for 113,837.15 hectares (281,297.72 acres) in Saskatchewan. The company also has a 100% interest in 12,545 hectares (31,000 acres), with rare earth element and uranium deposits over five mineralized zones in the Elliot Lake Camp, Ontario. Lastly, the company holds the right to acquire up to a 70% interest in the PCH Ionic Adsorption Clay Project, which is 17,551.07 ha. in size and located within the Goiás state of Brazil. For more information about the company, visit www.appiareu.com.

NOTE TO INVESTORS: The latest news and updates relating to APAAF are available in the company’s newsroom at https://ibn.fm/APAAF

About MiningNewsWire

MNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from MiningNewsWire, text “BigHole” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, CA
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is powered by IBN

Stanford Study Finds Lung Cancer Cells Hide, Thrive in the Brain

October 27, 2023 11:42:03

Researchers from Stanford Medicine have found that lung cancer cells can spread to the brain and hide from the immune system by pretending to be “baby neurons.” After originating in the lungs, these cancer cells can metastasize into the brain and avoid detection by convincing neural cells that they’re juvenile neurons through the secretion of a certain chemical signal.

These cancer cells secrete a chemical message/signal that is ubiquitous during times of brain development, which attracts brain cells called…

NOTE TO INVESTORS: The latest news and updates relating to CNS Pharmaceuticals Inc. (NASDAQ: CNSP) are available in the company’s newsroom at https://ibn.fm/CNSP

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

Study Shows Ketamine Acts Against TRD within Four Hours

October 27, 2023 11:11:46

Researchers from Sorbonne University have found that ketamine can reduce depression symptoms in patients with treatment-resistant depression (TRD) just four hours after infusion. Compared to healthy controls, patients with TRD reported feeling more optimistic a few hours after ketamine infusion, indicating that the psychedelic may have potent and fast-acting mental health benefits.

Prior studies have suggested that ketamine can alleviate depressive symptoms and reduce suicidal thoughts in some people, but this recent study sought to…

About PsychedelicNewsWire

To receive SMS alerts from PsychedelicNewsWire, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.PsychedelicNewsWire.com

PsychedelicNewsWire
San Francisco, CA
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]

PsychedelicNewsWire is powered by IBN

IEA Predicts 2030 Peak for Coal, Oil, Gas Energy

October 27, 2023 11:04:16

The International Energy Agency (IEA) predicts that global demand for coal, natural gas and oil will peak by 2030 amid an “unstoppable” energy transition. According to the agency, carbon pollution from the three fossil fuels will also peak by the end of the decade, thanks to the proliferation of renewable energy.

The IEA report predicted that there would be close to 10 times more electric cars than there are now by the end of 2030. Renewable energy sources such as…

About MiningNewsWire

MNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from MiningNewsWire, text “BigHole” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, CA
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is powered by IBN

Toyota Beats Tesla as Desirable EV Brand in US

October 27, 2023 10:57:25

Toyota has surpassed Tesla as the top electric vehicle brand in the United States with only one battery electric vehicle (BEV) model in the American market. While Tesla has several best-selling EVs, including the Model 3 and Model Y, Toyota has one — the bZ4X — along with the popular Toyota Prius and RAV4 Prime as its hybrid offerings.

The Japanese automaker is one of the only automakers that hasn’t invested in battery electric vehicles in recent years, focusing instead on hydrogen-powered, plug-in vehicles in…

About GreenCarStocks

To receive SMS alerts from GreenCarStocks, text “Green” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the GreenCarStocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

GreenCarStocks
Los Angeles, CA
www.GreenCarStocks.com
310.299.1717 Office
[email protected]

GreenCarStocks is powered by IBN

BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Secures $5.2M in Private Placement and Preferred Investment Option Offerings

October 27, 2023 10:51:34

InMed Pharmaceuticals (NASDAQ: INM) is a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs. The company today announced that it has closed its offering for the issuance and sale of 3,012,049 pre-funded warrants and preferred investment options to purchase up to an aggregate of 3,012,049 common shares, at a purchase price of $0.83 per pre-funded and associated preferred investment option, in a private placement priced at-the-market under Nasdaq rules. Per a previously announced definitive agreement with respect to certain of its outstanding preferred investment options issued in November 2022 and exercisable for 3,272,733 common shares, in the aggregate, the holders of such outstanding preferred investment options have exercised such investment options for cash at a reduced exercise price of $0.83 per share, in exchange for unregistered new preferred investment options to purchase up to 6,545,466 common shares. InMed secured approximately $5.2 million in aggregate gross proceeds, from which it intends to use the net proceeds to continue pipeline development of its pharmaceutical drug candidates, support commercial sales of rare cannabinoids through its subsidiary BayMedica LLC, and for general working capital purposes. H.C. Wainwright & Co. acted as the exclusive placement agent for the offerings.

To view the full press release, visit https://ibn.fm/1ymuD

About InMed Pharmaceuticals Inc.

InMed Pharmaceuticals is a global leader in the research, development, manufacturing and commercialization of rare cannabinoids, including clinical and preclinical programs targeting the treatment of diseases with high unmet medical needs. The company also has significant know-how in developing proprietary manufacturing approaches to produce cannabinoids for various market sectors. For more information, visit www.InMedPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://ibn.fm/INM

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

InvestorNewsBreaks – Gratomic Inc. (TSX.V: GRAT) (OTCQX: CBULF) (FSE: CB82) Retains SP Angel Corporate Finance LLP of London

October 27, 2023 10:15:38

Gratomic (TSX.V: GRAT) (OTCQX: CBULF) (FSE: CB82) announced that it has retained SP Angel Corporate Finance LLP (“SPA”) of London, U.K., to act as nominated advisor and broker in connection with the proposed admission of the company’s securities to the Alternative Investment Market (“AIM”) of the London Stock Exchange (“LSE”). The admission process generally takes three to four months and will require Gratomic to obtain a Competent Person’s Report relating to the properties of the company. As the company’s nominated advisor, SPA is responsible to the LSE for assessing the appropriateness of Gratomic for AIM and for advising and guiding the company on its responsibilities under the AIM rules both in respect of its admission and its continuing obligations. The company’s admission to AIM remains conditional on, amongst other things, it meeting the eligibility requirements set out in the AIM rules for companies. Gratomic has identified the competent person to prepare the Competent Person’s Report and is positioned to establish a timeline for the process.

To view the full press release, visit https://ibn.fm/WrK1T

About Gratomic Inc.

Gratomic is a multinational company with projects in Namibia, Brazil and Canada. The company is focused on becoming a leading global graphite supplier and aims to secure a strong position in the EV battery supply chain. With the continued development of its flagship Aukam Project and further exploration on the company’s Capim Grosso property, Gratomic sets itself apart by seeking out unique top-quality assets around the world. True to its roots, the company will continue to explore graphite opportunities displaying potential for development. The company ranked third place in the top 10 performing mining stocks on the 2022 TSX Venture 50(TM). For more information about the company, visit www.Gratomic.ca.

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Siyata Mobile Inc. (NASDAQ: SYTA) Announces Pricing of $1.6M Public Offering

October 27, 2023 10:08:03

Siyata Mobile (NASDAQ: SYTA), a global developer and vendor of push-to-talk over cellular (“PoC”) handsets and accessories, today announced the pricing of a public offering of 2,400,000 common shares (or pre-funded warrants to purchase common shares in lieu thereof) at a public offering price of $0.65 per share. The gross proceeds to Siyata are expected to be approximately $1.6 million, from which the company intends to use the net for working capital and general corporate purposes. Subject to customary conditions, the offering is expected to close on or about Oct. 31, 2023. Maxim Group LLC is acting as the sole placement agent in connection with the offering.

To view the full press release, visit https://ibn.fm/lAzBA

About Siyata Mobile Inc.

Siyata Mobile is a B2B global developer and vendor of next-generation push-to-talk (“PTT”) over cellular handsets and accessories. Its portfolio of rugged PTT handsets and accessories enables first responders and enterprise workers to instantly communicate over a nationwide cellular network of choice to increase situational awareness and save lives. Police, fire and ambulance organizations as well as schools, utilities, security companies, hospitals, waste management companies, resorts and many other organizations use Siyata PTT handsets and accessories today. In support of its PTT handsets and accessories, Siyata also offers enterprise-grade in-vehicle solutions and cellular booster systems enabling its customers to communicate effectively when they are in their vehicles, and even in areas where the cellular signal is weak. Siyata sells its portfolio through leading North American cellular carriers and through international cellular carriers and distributors. Siyata’s common shares and its previously issued warrants trade on the Nasdaq under the symbols SYTA and SYTAW, respectively. Visit SiyataMobile.com and UnidenCellular.com to learn more.

NOTE TO INVESTORS: The latest news and updates relating to SYTA are available in the company’s newsroom at https://ibn.fm/SYTA

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Reports on Publication of Low-Dose Suramin for ASD Research

October 27, 2023 10:01:56

PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company, announced that its groundbreaking research will be published in the “Annals of General Psychiatry,” an internationally recognized scientific psychiatry publication. The research was reported in a manuscript titled “Randomized clinical trial of low-dose suramin intravenous infusions for treatment of autism spectrum disorder,” which will be published by the psychiatry publication. Written by PaxMedica chief medical officer Dr. David Hough, MD, along with nine coauthors, the article reports on the potential of monthly suramin intravenous infusions as a safe and potentially efficacious treatment for the core symptoms of autism spectrum disorder (“ASD”). Coauthors of the article include Alice Mao, MD; Michael Aman, PhD; Reymundo Lozano, MD, MS; Constance Smith-Hicks, MD, PhD; Veronica Martinez-Cerdeno, PhD; Michael Derby; Zachary Rome; Miel Malan, MD; and Robert Findling, MD. An open access journal emphasizing a biopsychosocial approach to illness and health, the “Annals of General Psychiatry” supports the principles of evidence-based medicine, further validating the significance of this research. “The acceptance of this manuscript represents a significant milestone in PaxMedica’s continued dedication to pioneering innovative treatments for autism spectrum disorder,” said PaxMedia chief medical officer Dr. David Hough in the press release. “We are honored to contribute to the field of psychiatry with this significant research, underscoring our commitment to advancing the understanding and treatment of ASD.”

To view the full press release, visit https://ibn.fm/DLvhG

About PaxMedica Inc.

PaxMedica is a forward-looking, clinical-stage biopharmaceutical firm specializing in cutting-edge, anti-purinergic drug therapies (“APT”) designed to address challenging neurologic disorders. Its scope encompasses a spectrum of conditions, from neurodevelopmental disorders, including autism spectrum disorder (“ASD”) to the debilitating myalgic encephalomyelitis/chronic fatigue syndrome (“ME/CFS”), marked by both physical and cognitive burdens. PaxMedica prioritizes the advancement and evaluation of its flagship program, PAX-101 — an intravenous suramin formulation — primarily focused on ASD treatment, while also broadening clinical insights into its potential applications for conditions such as ME/CFS. For more information about the company, visit www.PaxMedica.com.

NOTE TO INVESTORS: The latest news and updates relating to PXMD are available in the company’s newsroom at https://ibn.fm/PXMD

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

How Blockchain Analysis Can Help Recover Stolen Crypto

October 27, 2023 09:35:00

In the ever-changing landscape of decentralized finance and the wider Web3 sphere, security is a top priority. With the constant emergence of new threats, it is crucial to analyze attack patterns to assess risk and reliability. Cointelegraph’s Crypto Hacks database indicates that almost $1 billion worth of crypto was stolen or lost in 2023 alone.

In response to the increasing need for security, a wide range of Web3 security specialists has emerged, from smart contract auditors to decentralized identification solutions, guaranteeing the security of an ever-evolving digital landscape. Yet, a persistent menace continues: the Lazarus Group, a…

About CryptoCurrencyWire

To receive SMS alerts from CryptoCurrencyWire, text “CRYPTO” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.CryptoCurrencyWire.com

CryptoCurrencyWire
New York, NY
www.CryptoCurrencyWire.com
212.994.9818 Office
[email protected]

CryptoCurrencyWire is powered by IBN

InvestorNewsBreaks – LQwD Fintech Corp. (TSX.V: LQWD) (OTC: LQWDF) Reports on Voting Results of Annual General Meeting

October 27, 2023 09:16:30

LQwD Fintech (TSX.V: LQWD) (OTC: LQWDF), a Lightning Network service provider, is reporting on its annual general meeting of shareholders. According to the announcement, the meeting was held on Oct 25, 2023; all proposed resolutions were passed during the meeting. The report noted that a total of 2,511,756 common shares were voted at the meeting, which represented 21.65% of the votes attached to all outstanding company common shares. Specifically, shareholders voted to fix the number of company directors at five. In addition, shareholders elected five directors to serve on the LQwD board of directors. Those individuals are Shone Anstey, Alex Guidi, Kim Evans, Giuseppe (Pino) Perone and Ashley Garnot. Shareholders also voted to appoint Kingston Ross Pasnak LLP as company auditor for the upcoming year and authorized company directors to decide payment for those auditing services. Finally, shareholders approved the company’s incentive stock option plan.

To view the full press release, visit https://ibn.fm/ZUImR

About LQwD Fintech Corp.

LQWD is a Lightning Network Liquidity provider focused on developing payment infrastructure and solutions accelerating the global megatrend of Bitcoin adoption through the Lightning Network. LQWD also owns Bitcoin that is used as an operating asset establishing nodes and payment channels on the Lightning Network. For more information, please visit www.LQwDFintech.com.

NOTE TO INVESTORS: The latest news and updates relating to LQWDF are available in the company’s newsroom at https://ibn.fm/LQWDF

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – RYVYL Inc. (NASDAQ: RVYL) Reports Record Preliminary Q3 2023 Revenues, Announces Earnings Conference Call

October 27, 2023 09:09:34

RYVYL (NASDAQ: RVYL), a leading innovator of payment-transaction solutions leveraging proprietary blockchain ledger and electronic token technology for the diverse international markets, is reporting anticipated third-quarter 2023 revenues will increase 60% compared to the same quarter in 2022, reaching a new company quarterly record of an estimated $17 million. According to the announcement, the company plans to release its full Q3 2023 financial results on Monday, Nov. 13, 2023, after the market closes. The company also announced that at 4:30 p.m. ET on that same day, management will host an earnings conference call and webinar. During the event, company officials will provide an overview of RYVYL’s financial results for the quarter ended Sept. 30, 2023; the event will also include a corporate update and an interactive Q&A session. To access the call, dial 1-844-826-3035 (in the United States) or 1-412-317-5195 (internationally). A replay of the conference call will be available through Jan. 13, 2023, by dialing 1-844-512-2921 (in the United States) or 1-412-317-6671 (internationally) and using the access ID 10183517. An archived version of the event will also be available on the company’s website.

To view the webcast, visit https://ibn.fm/zqUDP

To view the full press release, visit https://ibn.fm/vXupR

About RYVYL

RYVYL was born from a passion for empowering a new way to conduct business-to-business, consumer-to-business, and peer-to-peer payment transactions around the globe. By leveraging proprietary blockchain ledger and electronic token technology for the diverse international markets, RYVYL is a leading innovator of payment transaction solutions reinventing the future of financial transactions. Since its founding as GreenBox POS in 2017, RYVYL has developed applications enabling an end-to-end suite of turnkey financial products with enhanced security and data privacy, world-class identity theft protection, and rapid speed to settlement. As a result, the platform can log immense volumes of immutable transactional records at the speed of the internet for first-tier partners, merchants and consumers around the globe. For more information about the company, please visit www.RYVYL.com.

NOTE TO INVESTORS: The latest news and updates relating to RVYL are available in the company’s newsroom at https://ibn.fm/RVYL

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

PaxMedica Inc.’s (NASDAQ: PXMD) CEO and Corporate Communications Chief Discuss Regulatory Strategy for Lead Drug Candidate and Future Plans in Recent Bell2Bell Podcast Interview

October 27, 2023 08:50:00

PaxMedica Chairman and CEO Howard Weisman participated in a recent Bell2Bell Podcast interview and was joined by Buzz Woods from Corporate Communications
Weisman discussed the company’s strategy to seek FDA approval for Suramin as a treatment for Human African Trypanosomiasis (“HAT”) and plans for 2024
If PaxMedica is successful in getting approval in HAT, the company believes that could lead to the receipt of a Priority Review Voucher (“PRV”)
The company hopes to monetize the PRV to raise funds that will support research and future trials investigating Suramin as a treatment for Autism Spectrum Disorder
PaxMedica hopes to file an investigational new drug application to use Suramin in a large-scale trial in the U.S. in 2024

PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company specializing in innovative treatments for unmet needs in neurodevelopmental disorders, has recently introduced a groundbreaking regulatory strategy that could potentially pave the way for the approval of its lead product candidate, Suramin, in the United States. During a recent episode of the Bell2Bell (“B2B”) Podcast, Chairman and CEO Howard Weisman, along with Buzz Woods from Corporate Communications, delved into this strategy.

To hear the interview, please visit…

NOTE TO INVESTORS: The latest news and updates relating to PXMD are available in the company’s newsroom at https://ibn.fm/PXMD

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

InvestorNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Inks Gold Purchasing Agreement with Precious Metals Group

October 27, 2023 08:46:45

Blue Hat Interactive (NASDAQ: BHAT), through its wholly owned subsidiary, has signed a framework agreement with Macau Rongxin Precious Metals Technology Ltd. According to the announcement, the agreement outlines plans to purchase 1,000 kilograms of gold. The company noted that gold is a well-recognized, time-tested financial approach to hedge against inflation, geopolitical turmoil and macroeconomic uncertainty because the precious metal historically has reduced yield risk. The metal also helps steady revenue growth. “This represents a major step forward in the jewelry (gems, semiprecious stones, precious stones, jade, etc.) and bulk commodity gold business for the company,” said Blue Hat Interactive chief operating officer Weicheng Pan in the press release. “Going forward, gold will become a vital aspect of BHAT’s current commodity trade business.”

To view the full press release, visit https://ibn.fm/KEXn2

About Blue Hat Interactive Entertainment Technology

Blue Hat is developing a commodity trading with artificial intelligence analysis focus.

NOTE TO INVESTORS: The latest news and updates relating to BHAT are available in the company’s newsroom at http://ibn.fm/BHAT

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) to Showcase Its Boutique End-to-End CDMO Services at the Premier CPHI Barcelona Event

October 27, 2023 08:05:00

Scinai will exhibit at the upcoming CPHI Barcelona event, showcasing its CDMO services
The company expanded into the CDMO business earlier this year, operating under the banner Scinai Bioservices
Scinai’s boutique end-to-end CDMO business division serves pharmaceutical, biotech, and alternative protein food tech companies with pilot and clinical process development and cGMP manufacturing
Scinai intends to serve small biotech companies who require CDMO services with superior value compared to large, multinational CDMO companies
Scinai will also exhibit at the upcoming BIO-Europe conference in Munich

Scinai Immunotherapeutics (NASDAQ: SCNI), a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products, will be showcasing its Contract Development and Manufacturing Organization (“CDMO”) services at CPHI Barcelona, a premier three-day event that brings together pharmaceutical professionals, industry leaders, and businesses to advance human health. The event is scheduled for October 24 to 26, 2023, at Fira Barcelona Gran Via, Spain (https://ibn.fm/veEp4).

The company has been allocated Booth 81HA11, where potential partners and clients of the company’s CDMO service will get to meet several members of Scinai’s executive leadership team. Registered attendees may also request one-on-one meetings through the…

NOTE TO INVESTORS: The latest news and updates relating to SCNI are available in the company’s newsroom at https://ibn.fm/SCNI

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

420 with CNW — Marijuana Contaminants Could Have Health Risks for Users

October 27, 2023 03:25:00

Cannabis use, whether for medical or recreational purposes, may have adverse effects due to the presence of harmful fungi contaminating the plants, according to a recent peer-reviewed study. The study, published in the “Frontiers in Microbiology” journal, employed data derived from earlier studies, combined with U.S. and international regulations related to the marijuana industry. The researchers examined various contaminants, including mucor, fusarium, penicillium, aspergillus and other fungi capable of infecting cannabis plants and generating mycotoxins.

The findings showed that specific fungi could induce infections in lung and skin tissues, with such infections being more prevalent when marijuana is smoked compared to…

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is powered by IBN

420 with CNW — Study Says Male Cannabis Users Are at Lower Risk for Kidney Stones

October 26, 2023 15:25:00

A recent study suggests that men who regularly use cannabis have a lower likelihood of experiencing kidney stones. Researchers who analyzed data spanning from 2009 to 2018, sourced from the National Health and Nutrition Examination Survey (NHANES), found that male cannabis users exhibited a significant 28% decrease in the odds of reporting kidney stones compared to nonusers.

Furthermore, research showed that men who used cannabis between one and seven times per week had even more favorable odds, with a substantial 38% reduction in the likelihood of…

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is powered by IBN

InvestorNewsBreaks – AtomBeam Technologies Inc. Reaches $600K Milestone on StartEngine

October 26, 2023 15:15:34

AtomBeam, a technology company driving hyper-efficient machine communication, has achieved a significant milestone by reaching the $600,000 mark in its ongoing fundraising campaign hosted on the StartEngine investment platform. According to the announcement, AtomBeam’s capital raising campaign has seen one of the strongest openings on StartEngine recently, rapidly gaining the attention and support of investors. AtomBeam’s compaction software redefines data management through its near real-time reduction of machine-generated files and has resonated strongly with backers who recognize its immense potential. Funds raised through this campaign will play a pivotal role in further advancing AtomBeam’s technology and commercialization. “Reaching the $600,000 milestone underscores the confidence investors have in AtomBeam’s vision and technology,” said the company’s CEO Charles Yeomans. “We think it is great that so many investors can see what we see — this technology can change the world.”

To view the full press release, visit https://ibn.fm/jBA6x

About AtomBeam Technologies Inc.

AtomBeam is a pioneering data compaction software company that is revolutionizing the way data is transmitted and stored. With a strong focus on IoT connectivity and data compaction, AtomBeam’s groundbreaking technology offers enhanced efficiency, security and speed. Its successful crowdfunding campaign, raising over $3 million, highlights the industry’s recognition of AtomBeam’s innovative solutions. AtomBeam continues to lead the charge in transforming the data landscape, with a mission to empower businesses and individuals with advanced data compaction technology. For more information, visit AtomBeamTech.com.

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Study Suggests Psilocybin Could Manage Childhood Trauma

October 26, 2023 14:56:48

A recent Canadian study has suggested that psilocybin, the main hallucinogenic agent in magic mushrooms, may ease the psychological distress associated with childhood trauma. Researchers say the psychedelic seemed to offer “particularly strong benefits” to individuals who faced extremely severe adversity during childhood.

Led by a team of researchers from Athabasca University, the University of British Columbia, Simon Fraser University and the University of Michigan, the…

About PsychedelicNewsWire

To receive SMS alerts from PsychedelicNewsWire, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.PsychedelicNewsWire.com

PsychedelicNewsWire
San Francisco, CA
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]

PsychedelicNewsWire is powered by IBN

Swedish Scientists Find Promising Way to Recover Minerals from Discarded EV Batteries

October 26, 2023 14:47:00

Electric vehicle battery metals are poised to see a major increase in demand over the next couple of decades, thanks to soaring EV adoption. Minerals such as lithium, graphite and cobalt are critical to the development of EV batteries, but their production is almost completely reliant on Chinese companies, something that has left Western pundits and lawmakers extremely worried. Furthermore, the lack of efficient battery recycling techniques makes it incredibly difficult to reuse EV battery minerals and places even more pressure on the world’s already strained supply.

According to a team of Swedish researchers, they may have developed a technique that could allow the auto industry to recycle old electric vehicle batteries and…

NOTE TO INVESTORS: The latest news and updates relating to Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) are available in the company’s newsroom at https://ibn.fm/RFLXF

About MiningNewsWire

MNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from MiningNewsWire, text “BigHole” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, CA
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is powered by IBN

AINewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS), QuantumBasel Announce Two-Year Agreement Extension to Fuel Quantum Commercial Adoption

October 26, 2023 14:42:26

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services as well as the world’s first commercial supplier of quantum computers, has extended its relationship with QuantumBasel. In addition, according to the announcement, D-Wave is planning to open a European office on the QuantumBasel campus to support the companies’ collaboration in fast tracking the commercialization of quantum computing in the region and facilitating increased development of near-term quantum applications for businesses, governments and researchers.

QuantumBasel is Switzerland’s first quantum hub for commercial use embedded in the uptownBasel innovation campus, which serves as a global hub for Industry 4.0, seamlessly connected to the world while firmly rooted in Basel, Switzerland. Among D-Wave’s annealing quantum computing solutions is the Advantage(TM) system, a fifth-generation annealing quantum system that features more than 5,000 qubits and 15-way connectivity.

“QuantumBasel and D-Wave share a vision of solving the world’s most complex problems for the betterment of industry and society,” said D-Wave Quantum CEO Dr. Alan Baratz in the press release. “Today’s announcement reflects strong progress toward achieving that mission, as joint customers are quickly realizing the near-term advantage of D-Wave’s quantum technology. Through our collaboration and now our plans for a European office presence, we anticipate accelerated momentum for quantum and quantum-hybrid applications moving into production and fueling operations.”

To view the full press release, visit https://ibn.fm/LSgon

About D-Wave Quantum Inc.

D-Wave is a leader in the development and delivery of quantum computing systems, software and services, and is the world’s first commercial supplier of quantum computers — and the only company building both annealing quantum computers and gate-model quantum computers. The company’s mission is to unlock the power of quantum computing today to benefit business and society. D-Wave does this by delivering customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection and financial modeling. D-Wave’s customers include Volkswagen, Mastercard, Deloitte, Davidson Technologies, ArcelorMittal, Siemens Healthineers, Unisys, NEC Corporation, Pattison Food Group Ltd., DENSO, Lockheed Martin, Forschungszentrum Jülich, University of Southern California and Los Alamos National Laboratory. For more information about the company, please visit www.DWaveSys.com.

Forward-Looking Statements

Certain statements in this newsbreak are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. Forward-looking statements in this newsbreak include, but are not limited to, statements regarding D-Wave’s plans to open a European office on the QuantumBasel campus and the potential results of the collaboration between D-Wave and uptownBasel. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management’s control, including general economic conditions and other risks; our ability to expand our customer base and the customer adoption of our solutions; risks within D-Wave’s industry, including anticipated trends, growth rates, and challenges for companies engaged in the business of quantum computing and the markets in which they operate; the outcome of any legal proceedings that may be instituted against us; risks related to the performance of our business and the timing of expected business or financial milestones; unanticipated technological or project development challenges, including with respect to the cost and/or timing thereof; the performance of our products; the effects of competition on our business; the risk that we will need to raise additional capital to execute our business plan, which may not be available on acceptable terms or at all; the risk that we may never achieve or sustain profitability; the risk that we are unable to secure or protect our intellectual property; volatility in the price of our securities; the risk that our securities will not maintain the listing on the NYSE; and the numerous other factors set forth in D-Wave’s Annual Report on Form 10-K for its fiscal year ended December 31, 2022 and other filings with the Securities and Exchange Commission. Undue reliance should not be placed on the forward-looking statements in this newsbreak in making an investment decision, which are based on information available to us on the date hereof. We undertake no duty to update this information unless required by law.

NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

About AINewsWire

AINewsWire (“AINW”) is a specialized communications platform with a focus on the latest advancements in artificial intelligence (“AI”), including the technologies, trends and trailblazers driving innovation forward. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, AINW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, AINW brings its clients unparalleled recognition and brand awareness.

AINW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from AINewsWire, text “AI” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit www.AINewsWire.com

Please see full terms of use and disclaimers on the AINewsWire website applicable to all content provided by AINW, wherever published or re-published: https://www.AINewsWire.com/Disclaimer

AINewsWire
Los Angeles, CA
www.AINewsWire.com
310.299.1717 Office
[email protected]

AINewsWire is powered by IBN

EV Shoppers Can Now Access Significant Discounts as Sales Stutter

October 26, 2023 14:05:32

After prohibitively high prices have prevented most drivers from purchasing electric cars for several years, increased competition coupled with reduced demand is making electric cars more affordable. Electric cars have been out of the reach of most consumers for nearly a decade thanks to high prices, keeping a majority of drivers from buying EVs and lowering EV adoption rates.

Early adopters and high-earning individuals who love to have the latest technology already own electric vehicles, Edmunds consumer insights analyst Joseph Yoon says, and the…

About GreenCarStocks

To receive SMS alerts from GreenCarStocks, text “Green” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the GreenCarStocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

GreenCarStocks
Los Angeles, CA
www.GreenCarStocks.com
310.299.1717 Office
[email protected]

GreenCarStocks is powered by IBN

Biotech Firms Register Successes in Quest for Better Pancreatic Cancer Treatments

October 26, 2023 13:52:48

The American Cancer Society’s Cancer Facts & Figures 2023 report revealed a 1% increase in five-year survival rates for pancreatic cancer, which increased from 11% to 12%. Released in early 2023, the report represented the first instance since 2017 that five-year survival rates for pancreatic cancer increased for two years in a row.

It indicates that we are making slow but steady progress against pancreatic cancer, a hard-to-treat cancer that originates in the pancreas before spreading to…

NOTE TO INVESTORS: The latest news and updates relating to Renovaro BioSciences Inc. (NASDAQ: RENB) are available in the company’s newsroom at https://ibn.fm/RENB

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

CryptoNewsBreaks – Diamond Lake Minerals Inc. (DLMI) Expands Leadership Team, Eyes Bright Future

October 26, 2023 13:47:37

Diamond Lake Minerals (OTC: DLMI), a leading multi-strategy operating company specializing in the development and support of digital assets and SEC-registered security tokens, previously announced the release of its new company mark and logo, as well as a significant transition in leadership by welcoming Brian J. Esposito as its new chief executive officer. As a renowned entrepreneur and business leader, Esposito brings to the company a proven track record of driving growth and innovation. “It is with great pleasure to announce that after 7 years my search for the right CEO to take this company forward has finally ended. It is a rarity to find, in this day and age, a seasoned executive and leader who has not only overcome and accomplished what Mr. Esposito has, but also someone who respects and values old-school business principles and philosophies,” Michael Reynolds, president and director of Diamond Lake Minerals, said of the appointment. “He is someone who understands how to truly build shareholder value and can handle himself extremely well in any situation. I have all the confidence in the world that Diamond Lake Minerals is in the right hands and expect to see great things for this wonderful company and all its current and future shareholders.”

To view the full press release, visit https://ccw.fm/e7SR8

About Diamond Lake Minerals Inc.

Founded in Utah in 1954, Diamond Lake Minerals is a multi-strategy operating company that specializes in the development and support of digital assets and SEC-registered security tokens. Its goal is to responsibly innovate and develop valuable traditional businesses and successfully combine them with the future of money, digital assets. Diamond Lake’s mission is to bring back to the public markets timeless business principles that are focused on healthy sustainable growth, strong earnings that generate yields combined in a modern digital world creating value for its stakeholders. DLMI is positioning itself as an industry agnostic leader in the digital asset and security token space. For more information, visit the company’s website at www.DiamondLakeMinerals.com.

About CryptoCurrencyWire

To receive SMS alerts from CryptoCurrencyWire, text “CRYPTO” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.CryptoCurrencyWire.com

CryptoCurrencyWire
New York, NY
www.CryptoCurrencyWire.com
212.994.9818 Office
[email protected]

CryptoCurrencyWire is powered by IBN

GreenEnergyBreaks – Astra Energy Inc. (ASRE), HES and SETI to Exhibit at Fort Lauderdale International Boat Show

October 26, 2023 13:37:28

Astra Energy (OTCQB: ASRE), an innovative clean and renewable energy solution provider, together with Holcomb Energy Systems LLC (“HES”) and Sustainable Energy Technologies, Inc. (“SETI”), is exhibiting at the Fort Lauderdale International Boat Show (“FLIBS”) today through Oct. 29, 2023. Sponsored by Camper and Moretti Yacht Group, FLIBS 2023 is the world’s largest boat show, promoting luxury, innovation, sustainable initiatives, and cutting-edge designs. The event provides an optimal setting to unveil the HES In-Line Power Generator (“ILPG”) and the SETI Power Pack, breakthrough technologies that will cut fuel consumption and harmful emissions — a “sea-change” in power use for the marine industry. This marks Astra’s first exposure into the marine industry through Camper and Moretti Yacht Group, addressing the growing demand for sustained and sustainable energy for the maritime community.

To view the full press release, visit https://ibn.fm/H4OeJ

About Astra Energy Inc.

Astra is an integrated solutions provider investing in and developing clean and renewable energy projects in markets where demand is high, supply is limited and there is an opportunity to address other imminent market needs. Astra’s corporate strategy is rooted in securing technologies and assets; identifying viable market opportunities; and bringing together resources, expertise, technology, and defined action plans to execute first-in-class projects that benefit communities, local economies, the planet, and the company’s investors. Its goal is to create a more secure and sustainable power sector that supports the company’s purpose, mission and values to transform the economic, environmental and social landscape for generations to come. For more information on Astra Energy Inc., visit the company’s website at www.astraenergyinc.com

About GreenEnergyStocks

To receive SMS alerts from GreenEnergyStocks, text “Green” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenEnergyStocks.com

Please see full terms of use and disclaimers on the GreenEnergyStocks website applicable to all content provided by GES, wherever published or re-published: https://www.greennrgstocks.com/Disclaimer

GreenEnergyStocks
Los Angeles, CA
www.GreenEnergyStocks.com
310.299.1717 Office
[email protected]

GreenEnergyStocks is powered by IBN

GolfLync Inc. Unveils Exciting Updates to Enhance Your Golfing Experience

October 26, 2023 13:35:00

GolfLync, the leading social networking platform for golfers, is thrilled to announce a major update to its app, bringing a host of new features members will enjoy!

Travel Mode: Play Golf Anywhere, Anytime
Golf and travel often go hand in hand, and GolfLync recognizes this synergy. The new Travel Mode allows members to change their location and seamlessly plan games, discover clubs, and connect with players in the area they are traveling to. Whether you’re on a business trip, vacation, or simply exploring…

NOTE TO INVESTORS: The latest news and updates relating to GolfLync are available in the company’s newsroom at https://ibn.fm/GOLF

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

BioMedNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Clearing Path to Submit NDA for PAX-101

October 26, 2023 13:33:26

PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company, today announced the completion of a type-B meeting with the FDA. During the live meeting, the company discussed positive results of the recent data from its PAX-HAT-301 study of suramin in stage one human African sleeping sickness caused by trypanosoma brucei rhodesiense, a rare and fatal parasitic disease if left untreated. According to the announcement, PaxMedica received constructive feedback that will aid in the completion of the remaining work necessary to file a New Drug Application (“NDA”) expected in the second half of 2024. “This is an important turning point for our young company, and we are very pleased with the guidance that the FDA has provided us in this meeting,” said Howard Weisman, CEO and chairman of PaxMedica. “We look forward to urgently completing the necessary steps in the coming months to clear the path to submit our first NDA for PAX-101.”

To view the full press release, visit https://ibn.fm/wT1eM

About PaxMedica Inc.

PaxMedica is a forward-looking clinical-stage biopharmaceutical firm specializing in cutting-edge anti-purinergic drug therapies (“APT”) designed to address challenging neurologic disorders. Its scope encompasses a spectrum of conditions, from neurodevelopmental disorders, including autism spectrum disorder (“ASD”), to the debilitating myalgic encephalomyelitis/chronic fatigue syndrome (“ME/CFS”), marked by both physical and cognitive burdens. PaxMedica prioritizes the advancement and evaluation of its flagship program, PAX-101—an intravenous suramin formulation—primarily focused on ASD treatment, while also broadening clinical insights into its potential applications for conditions such as ME/CFS. For more information, visit www.PaxMedica.com.

NOTE TO INVESTORS: The latest news and updates relating to PXMD are available in the company’s newsroom at https://ibn.fm/PXMD

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) to Effect a Reverse Stock Split

October 26, 2023 13:22:56

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for patients suffering from mild-to-moderate obstructive sleep apnea (“OSA”) and snoring in adults, today announced that it will effect a 1-for-25 reverse stock split of its issued and outstanding common stock, effective with the opening of trading on Friday, Oct. 27, 2023. Vivos’ common stock will continue trading on the Nasdaq Capital Market under the symbol VVOS, with a new CUSIP number of 92859E207 for the common stock following the reverse split. The reverse stock split was approved at Vivos’ 2023 annual meeting of stockholders held on Sept. 22, 2023. At the meeting, Vivos’ stockholders approved a proposal to authorize a reverse stock split of the common stock at a ratio of between 1-for-10 and 1-for-30, with the exact ratio to be determined by the Vivos’ board of directors in its sole discretion.

To view the full press release, visit https://ibn.fm/ELPF9

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as mild-to-moderate obstructive sleep apnea (“OSA”) and snoring in adults. The Vivos Method represents the first clinically effective nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution for treating mild-to-moderate OSA in adults. It has proven effective in approximately 40,000 patients treated worldwide by more than 1,800 trained dentists. The Vivos Method includes the Vivos Complete Airway Repositioning and/or Expansion (“CARE”) appliance therapy and associated protocols that alter the size, shape and position of the soft tissues that comprise a patient’s upper airway and/or palate. The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild-to-moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos Integrated Practice (“VIP”) program offers dentists training and other value-added services in connection with using The Vivos Method. For more information, visit www.Vivos.com.

NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS

*Katz D, Demaria S, Heckman S, Lin F, Kushida C. Use of the Complete Airway Repositioning and Expansion (CARE) approach in 220 patients with Obstructive Sleep Apnea (OSA): A retrospective cohort study. Sleep Med. 2022 Nov;99:18-22.

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Expands Portfolio to Secure New European Patent

October 26, 2023 13:15:06

Cybin (NYSE American: CYBN) (NEO: CYBN) is a clinical-stage biopharmaceutical company committed to revolutionizing mental health care by developing new and innovative psychedelic-based treatment options. The company today announced that the European Patent Office (“EP”) has granted a patent protecting Cybin’s proprietary deuterated psilocybin analog and N, N-dimethyltryptamine (“DMT”) programs. “Maintaining a secure intellectual property position is fundamental to our development strategy as we continue to advance our novel molecules and optimize their therapeutic benefits,” said Doug Drysdale, chief executive officer of Cybin. “Following quickly on from the two recently announced U.S. patents granted in respect of our deuterated DMT program, this European patent further strengthens our intellectual property protection around our deuterated DMT and deuterated psilocybin programs. With 33 granted patents and over 170 pending applications, Cybin now has one of the most robust intellectual property portfolios in the psychedelic drug development sector.”

To view the full press release, visit https://ibn.fm/SqUDB

About Cybin Inc.

Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. Cybin’s goal of revolutionizing mental health care is supported by a network of world-class partners and internationally recognized scientists aimed at progressing proprietary drug discovery platforms, innovative drug delivery systems, and novel formulation approaches and treatment regimens. The company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland. For company updates and to learn more about Cybin, visit www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Exro Technologies Inc. (TSX: EXRO) (OTCQB: EXROF) Issues Operations Update

October 26, 2023 12:57:52

Exro Technologies (TSX: EXRO) (OTCQB: EXROF), a leading clean-technology company that develops new generation power-control electronics that expand the capabilities of electric motors and batteries, today provided a Q4 2023 letter to shareholders. In the update, Exro’s Chief Investment Officer Darrell Bishop and Chief Executive Officer Sue Ozdemir describe the transition to an electrified world as a matter of “when” rather than “if,” and discuss milestones and a commitment to finish the year strong. “Our technology is truly disruptive and acts as an accelerator to this new world by solving the total cost of ownership, performance and return on investment for our customers. At Exro, we are significantly reshaping the way the world consumes energy, solving these key challenges slowing adoption. We hear your frustration with respect to the recent share price weakness and share it as well. Since our start of production a month ago, we have witnessed an erosion of macro environment fundamentals contributing to this weakness. Recessionary fears, inflation, high interest rates, and ongoing geo-political developments are dominating investment uncertainty in capital markets,” the letter reads. “We continue to execute our strategy with customers while also taking prudent steps to manage costs to extend our cash runway. All customers’ and projects remain on track and in good standing.”

To view the full press release, visit https://ibn.fm/kabQ7

About Exro Technologies Inc.

Exro Technologies is a leading clean technology company that has developed new generation power control electronics that change how the world optimizes energy by expanding the capabilities of electric motors and batteries. The company’s innovative technologies serve to bridge the performance-cost gap in e-mobility (Coil Driver(TM)) and stationary energy storage (Cell Driver(TM)), and act to accelerate adoption towards a circular electrified economy by delivering more with less – minimum energy for maximum results. For more information, visit the company’s website at www.Exro.com.

NOTE TO INVESTORS: The latest news and updates relating to EXROF are available in the company’s newsroom at http://ibn.fm/EXROF

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

GreenCarNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Request to Continue Listing Is Granted by NASDAQ Hearings Panel

October 26, 2023 12:35:38

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, was notified by the NASDAQ Hearings Panel that its request to continue listing on the NASDAQ capital market has been granted with two conditions. Those conditions call for the company to maintain a closing bid price of $1 per share for 20 consecutive trading sessions on or before Jan. 22, 2024, and hold an annual shareholder meeting on or before March 8, 2024. According to the announcement, the company held a meeting on Aug. 3, 2023, where proposals were approved by shareholders, but shareholders did not have an opportunity to discuss company affairs with management at the meeting; the upcoming combined 2023 and 2024 annual meeting must include that opportunity in order to be compliant. “I am pleased NASDAQ gave the company this opportunity to continue implementing its business plan,” said Mullen Automotive CEO and share David Michery in the press release. “We are diligently working to regain and maintain compliance with NASDAQ’s continued listing requirements.”

To view the full press release, visit https://ibn.fm/JhunL

About Mullen Automotive Inc.

Mullen Automotive is a Southern California-based automotive company building the next generation of electric vehicles (“EVs”) that will be manufactured in its two United States-based assembly plants. Mullen’s EV development portfolio includes the Mullen FIVE EV Crossover; the Mullen I-GO Commercial Urban Delivery EV; the Mullen commercial class 1–3 EVs; and Bollinger Motors, which features both the B1 and B2 electric SUV trucks and class 4–6 commercial offerings. On Sept. 7, 2022, Bollinger Motors became a majority-owned EV truck company of Mullen Automotive, and on Dec. 1, 2022, Mullen closed on the acquisition of all Electric Last Mile Solutions (“ELMS”) assets, including all IP and a 650,000-square-foot plant in Mishawaka, Indiana. To learn more about the company, visit www.MullenUSA.com.

NOTE TO INVESTORS: The latest news and updates relating to MULN are available in the company’s newsroom at https://ibn.fm/MULN

About GreenCarStocks

To receive SMS alerts from GreenCarStocks, text “Green” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the GreenCarStocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

GreenCarStocks
Los Angeles, CA
www.GreenCarStocks.com
310.299.1717 Office
[email protected]

GreenCarStocks is powered by IBN

TechMediaBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Selected by Leading Pharmaceutical Giant for Vital Logistics Operation

October 26, 2023 12:05:00

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company offering its custom-developed Fr8App, an industry-leading freight-matching platform powered by AI and machine-learning and providing a real-time portal for B2B cross-border shipping and domestic shipping within the USMCA region. The company today announced a significant achievement with the recent success of securing an RFQ (Request for Quotation) from a leading global pharmaceutical giant. According to the announcement, the prestigious pharmaceutical conglomerate, renowned for its unwavering commitment to global health and life-changing innovations, has chosen Fr8App as its trusted partner for a crucial logistics operation. “We are incredibly proud and honored to have been chosen to undertake this vital logistics operation,” said Javier Selgas, CEO of Fr8Tech. “This achievement represents a significant step in our mission to provide world-class logistics services, especially in the pharmaceutical industry, where precision and reliability are paramount. Our team is ready and excited to meet the high expectations of our esteemed client.”

To view the full press release, visit https://ibn.fm/fRkFZ

About Freight Technologies Inc.

Freight Technologies (“Fr8Tech”) is a technology company developing solutions to optimize and automate the supply chain process. Its wholly owned subsidiary, Freight App Inc. (“Fr8App”), is a B2B cross-border shipping marketplace in the USMCA region powered by AI and machine learning. Focused on making shipping transparent and efficient, Fr8App provides carriers with increased growth opportunities and shippers with flexibility, visibility and simplicity for the once-complex process of international over-the-road (“OTR”) shipping. Fr8App uses its proprietary technology platform to connect carriers and shippers and significantly improve matching and operation efficiency via innovative technologies such as live pricing and real-time tracking, digital freight marketplace, broker, transportation management, fleet management, and committed capacity solutions. The company is headquartered in Houston, Texas. For more information, please visit Fr8Technologies.com.

NOTE TO INVESTORS: The latest news and updates relating to FRGT are available in the company’s newsroom at https://ibn.fm/FRGT

Corporate Communications
IBN (InvestorBrandNetwork)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

About TechMediaWire

To receive SMS alerts from TechMediaWire, text “TECH” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Los Angeles, CA
www.TechMediaWire.com
310.299.1717 Office
[email protected]

TechMediaWire is powered by IBN

InvestorNewsBreaks – Mydecine Innovations Group Inc. (CSE: MYCO) (AQSE: MYIG) (OTC: MYCOF) Reports on Company Progress in Q4 2023 Update

October 26, 2023 10:42:08

Mydecine Innovations (CSE: MYCO) (AQSE: MYIG) (OTC: MYCOF), a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and PTSD, has released a fourth-quarter 2023 company update. According to the update, the company has worked to simplify its business model, streamline workflow and processes, and reduce burn rate while increasing output and efficiencies in order to ensure future success. Consequently, the company has made key decisions designed to benefit shareholders and increase long-term success, including focusing on becoming a true preclinical biopharmaceutical platform developing novel next-generation, improved drugs.

The company is working to develop a truly successful drug for shareholders and patients by making several structural changes and improvements to the first-generation MDMA and psilocybin/psilocin compounds, including faster onset, increased safety, significantly reduced half-life, elimination of certain undesirable side effects and selective receptor binding. The company noted the importance of its exclusive partnership with Applied Pharmaceutical Innovation (“API”), which houses the company’s drug-discovery and development efforts at the University of Alberta. The company believes by channeling its MYCO-005, MYCO-006 and MYCO-007 families of novel, patent-pending second-generation MDMA and psilocybin analogs through API, it has the best chance to enhance the global pharmaceutical landscape with these new molecules. Mydecine is committed to advance its leading candidates toward human clinical trials and anticipates providing significant updates in the near future.

“We’ve been working diligently, but the last few years have been extremely difficult for the entire industry and our company,” said Mydecine Innovations CEO and chair Josh Bartch in the press release. “Through adversity, Mydecine has become a more robust, well-managed, streamlined, efficient and productive organization with a high likelihood of success. Recently, the industry has witnessed several strong catalysts that we believe provide a glimpse into the future, such as large successful financings with very notable participants, open market buys by notable investors such as Steve Cohen, MAPS publishing their second and final phase 3 with incredibly strong results and gearing up for FDA approval in early 2024, Mindset Pharma being acquired by Otsuka, and many others. . . . Our robust drug pipeline is full, and we believe we have made the necessary improvements to generation one drugs to maximize the commercial viability and monetization of psychedelic medicine. We look forward to sharing with you a multitude of incredibly thrilling developments soon.”

To view the full press release, visit https://ibn.fm/96dpr

About Mydecine Innovations Group Inc.

Mydecine Innovations is a publicly traded, prerevenue biopharmaceutical company that began operations in North America and Europe in early 2020. Mydecine was founded to increase physicians’ access to serotonin-modulating medicine. Recent research has demonstrated the therapeutic potential of psychedelic substances such as psilocybin and MDMA for treating intractable conditions such as pain, anxiety, depression, addiction and PTSD, along with neurodegenerative disorders. Mydecine believes these compounds can be safer, more effective and more accessible for patients and medical professionals through modern drug chemistry paired with artificial intelligence (“AI”). Through its exclusive partnership with Applied Pharmaceutical Innovation based at the University of Alberta, Mydecine is developing innovative medications for target indications with high mortality rates that have lacked innovation for decades and are controlled by dominant corporations. Mydecine developed several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. The company is also developing MYCO-006, short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. Mydecine utilizes cutting-edge AI and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make these medications affordable and accessible to the general public upon Health Canada and FDA approval. The Mydecine team is enthusiastic about its mission and is dedicated to creating a positive difference in the lives of others. For more information about the company, please visit www.Mydecine.com.

NOTE TO INVESTORS: The latest news and updates relating to MYCOF are available in the company’s newsroom at https://ibn.fm/MYCOF

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

TechMediaBreaks — SenesTech Inc. (NASDAQ: SNES) Brings Sustainable Solution for Rising Demand in ‘Rattiest Cities’

October 26, 2023 10:06:53

A recent Fox Business article discussed pest control company Orkin’s annual ranking of the “Top 50 Rattiest Cities,” where Chicago continues to top the list, followed by Los Angeles, New York City, Washington, D.C., and San Francisco. Rankings are based on the number of new rodent services showcasing the demand and efforts that residents and businesses of the top cities have taken to treat rodent issues. Among these are strategies such as cutting off rats’ food sources and developing new technologies to detect and exterminate rat populations. As an expert in animal fertility control and the inventor of the only EPA-registered contraceptive for male and female rats, SenesTech (NASDAQ: SNES) brings a sustainable and effective solution. Its ContraPest(R) and Evolve(TM) products fit seamlessly into all pest management programs, humanely managing animal population through fertility control.

To view the full article, visit https://ibn.fm/dvzFh

About SenesTech Inc.

SenesTech is an expert in animal fertility control. The company’s passion is to create a healthy environment by better controlling animal pest populations. Keeping an inescapable truth in mind—that two rats and their descendants can be responsible for the birth of up to 15,000 pups after a year—SenesTech invented ContraPest(R), the only U.S. EPA registered contraceptive for male and female rats, and Evolve(TM) minimum risk soft bait. Its products fit seamlessly into all integrated pest management programs, greatly improving the overall goal of effective pest management. SenesTech strives for clean cities, efficient businesses and happy households – with a product designed to be effective and sustainable. The company is committed to improving the health of the world by humanely managing animal populations through fertility control. For more information about the company, visit www.SenesTech.com.

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

About TechMediaWire

To receive SMS alerts from TechMediaWire, text “TECH” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Los Angeles, CA
www.TechMediaWire.com
310.299.1717 Office
[email protected]

TechMediaWire is powered by IBN

TechMediaBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0) Inks 2024 Media Contract with ‘New to the Street’ Program

October 26, 2023 09:11:12

Sekur Private Data (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0), a leading Swiss-hosted secure and private communications platform, is partnering with FMW Media Corp.’s “New to the Street,” one of the longest-running syndicated Nielsen-rated programming television brands. Sekur has signed a media contract with the platform; the agreement covers television airings and other multimedia content and streaming. According to the announcement, “New to the Street” will continue filming interviews with SWISF CEO Alain Ghiai, including the popular “Sekur Privacy & Sekur Security — The Weekly Hack” segment, which features Ghiai and host Ana Berry discussing key cybersecurity risks along with Sekur solutions. The announcement noted that the Sekur interviews spotlight the company’s proprietary, military-grade, Swiss-hosted encrypted communications platform services; the discussions also often note the importance of its operations being in Switzerland, a country with extremely tough privacy laws.

“The new contract with FMW Media’s TV show ‘New to the Street’ continues forward in 2024,” said Sekur Private Data CEO Alan Ghiai in the press release. “I’m confident that upcoming TV interviews and supportive ad campaigns can continue to inform the public about the company’s success in our Sekur privacy solutions. Viewers who become subscribers realize the numerous benefits of our company’s secure and private applications. With our continuation with ‘New to the Street’ and their sophisticated TV hosts, media production staff and writers, we feel that Sekur can continue to inform viewers about global cybersecurity issues and how we as a company can minimize risks for consumers as well as businesses throughout the USA and globally.”

To view the full press release, visit https://ibn.fm/QVLqH

About Sekur Private Data Ltd.

Sekur Private Data is a cybersecurity and internet privacy provider of Swiss-hosted solutions for secure and private communications. The company distributes a suite of encrypted e-mails, secure messengers and secure communication tools. Sekur Private Data sells its products through its own website as well as through approved distributors and telecommunications companies around the world. The company serves consumers, businesses and governments worldwide. For more information, visit the company’s website at www.Sekur.com.

NOTE TO INVESTORS: The latest news and updates relating to SWISF are available in the company’s newsroom at https://ibn.fm/SWISF

About TechMediaWire

To receive SMS alerts from TechMediaWire, text “TECH” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Los Angeles, CA
www.TechMediaWire.com
310.299.1717 Office
[email protected]

TechMediaWire is powered by IBN

DGE 4th Next Generation MSL Excellence Summit 2023: Navigating Thought Leader Engagement in the Digital Age

October 26, 2023 08:50:00

DGE’S 4th Next Generation MSL Excellence Summit will be held on November 13-14, 2023 in Philadelphia, along with a live streaming option. The event revolves around offering lucrative thought leader engagement strategies to MSLs and field executives along with data, tools, and tips to engage with their audiences. As remote meetings have become the preferred means of connection and communication post-covid, strategies need to be reshaped to meet the present challenges.

The event is hosted by Dynamic Global Events (“DGE”), a Life Science leader in organizing b2b events. The global event company caters to the dynamic informational and networking needs of the…

To know more, please visit https://ibn.fm/jiAlj

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

420 with CNW — Demand for Marijuana Seeds Booms as Legalization Spreads

October 26, 2023 03:25:00

Demand for cannabis seeds in America is surging. A wave of cannabis reform has left medical marijuana legal in 38 states, and recreational cannabis is now legal in 23 states. Now that thousands of commercial cultivators across the country can legally grow and produce cannabis, demand for seeds in the United States is skyrocketing.

State-level recreational cannabis policies that allow home cultivation have also contributed to the increase in marijuana seed demand. Since cannabis seeds barely contain any…

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is powered by IBN

420 with CNW — Studies Assert Cannabis’ Safety over Tobacco

October 25, 2023 15:25:00

Approximately twice as many individuals in the United States perceive that smoking cigarettes poses a more substantial threat to one’s well-being compared to smoking cannabis, and they are correct. Numerous investigations examining the prolonged health consequences of inhaling marijuana smoke dispel the myth that cannabis carries the same well-established detrimental respiratory risks as tobacco.

A case in point is the federally funded study conducted at the University of California where researchers examined the lifetime risk of developing lung cancer among more than…

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is powered by IBN

MiningNewsBreaks – IMARC 2023 to Showcase the Latest AI Applications and Strategies

October 25, 2023 14:37:20

IBN’s MiningNewsWire delves into trends in artificial intelligence (“AI”) in a recent article titled, “From Changing a Tire to Uncovering the Next Lode: How AI Is Revolutionizing the Mining Industry.” The piece discusses the mining industry’s positioning at the forefront of technological progress, with the adoption of AI in recent years emerging as a game changer, allowing for more efficient exploration, taking automation to new levels, generating greater yields, dramatically improving safety, and maximizing extraction, maintenance and operational performance. Featured within the publication are details surrounding the 2023 International Mining and Resources Conference (“IMARC”), which is taking place in Sydney, Australia, later this year. The event, IMARC COO Anita Richards says, is a unique opportunity to hear from miners, academia, METS and consultants on the latest AI applications and strategies that are helping drive productivity, safety, quality and sustainability. Richards is quoted as saying, “AI has rapidly emerged as a powerful tool in the mining industry, transforming traditional practices and catalyzing a new era of efficiency, safety and sustainability, and its impact is felt across the mining value chain.”

To view the full article, visit https://ibn.fm/wj15s

About IMARC

The International Mining and Resources Conference (“IMARC”) is where global mining leaders collaborate on trends in mining, investment and innovation towards a sustainable future. As Australia’s largest mining event, it brings together over 8,500 decision makers, mining leaders, policy makers, investors, commodity buyers, technical experts, innovators, and educators from more than 100 countries for three days of learning, deal-making and unparalleled networking. IMARC is developed in collaboration with its founding partners, the Victorian State Government, Austmine, the Australasian Institute of Mining and Metallurgy (“AusIMM”) and Mines and Money, and held with the support of its host partner, the NSW Government.

About MiningNewsWire

MNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from MiningNewsWire, text “BigHole” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, CA
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is powered by IBN

AINewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Schedules Q3 2023 Earnings Call

October 25, 2023 14:27:57

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services, has announced plans to report on its third-quarter financial results for the period ended Sept. 30, 2023. The company will issue its third quarter earnings press release before market opens on Nov. 9, 2023. In addition, D-Wave Quantum CEO Alan Baratz and CFO John Markovich will host a conference call on the same day; the call will begin at 8 a.m. ET. During the call, company officials will discuss D-Wave Quantum financial results as well as its business outlook. Those interested can access by call by dialing 1-800-908-9179 (domestic) or 1-312-281-1211 (international).

To view the full press release, visit https://ibn.fm/cLlkw

About D-Wave Quantum Inc.

D-Wave is a leader in the development and delivery of quantum computing systems, software and services, and is the world’s first commercial supplier of quantum computers — and the only company building both annealing quantum computers and gate-model quantum computers. The company’s mission is to unlock the power of quantum computing today to benefit business and society. D-Wave does this by delivering customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection and financial modeling. D-Wave’s technology is being used by some of the world’s most advanced organizations, including Volkswagen, Mastercard, Deloitte, Davidson Technologies, ArcelorMittal, Siemens Healthineers, Unisys, NEC Corporation, Pattison Food Group Ltd., DENSO, Lockheed Martin, Forschungszentrum Jülich, University of Southern California and Los Alamos National Laboratory. For more information about the company, please visit www.DWaveSys.com.

Forward-Looking Statements

Certain statements in this newsbreak are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. Forward-looking statements in this newsbreak include, but are not limited to, statements regarding the timing of the company’s release of financial results and the associated conference call. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management’s control, including general economic conditions and other risks; our ability to expand our customer base and the customer adoption of our solutions; risks within D-Wave’s industry, including anticipated trends, growth rates, and challenges for companies engaged in the business of quantum computing and the markets in which they operate; the outcome of any legal proceedings that may be instituted against us; risks related to the performance of our business and the timing of expected business or financial milestones; unanticipated technological or project development challenges, including with respect to the cost and/or timing thereof; the performance of our products; the effects of competition on our business; the risk that we will need to raise additional capital to execute our business plan, which may not be available on acceptable terms or at all; the risk that we may never achieve or sustain profitability; the risk that we are unable to secure or protect our intellectual property; volatility in the price of our securities; the risk that our securities will not maintain the listing on the NYSE; and the numerous other factors set forth in D-Wave’s Annual Report on Form 10-K for its fiscal year ended December 31, 2022 and other filings with the Securities and Exchange Commission. Undue reliance should not be placed on the forward-looking statements in this newsbreak in making an investment decision, which are based on information available to us on the date hereof. We undertake no duty to update this information unless required by law.”

NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

About AINewsWire

AINW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from AINewsWire, text “AI” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit www.AINewsWire.com

Please see full terms of use and disclaimers on the AINewsWire website applicable to all content provided by AINW, wherever published or re-published: https://www.AINewsWire.com/Disclaimer

AINewsWire
Los Angeles, CA
www.AINewsWire.com
310.299.1717 Office
[email protected]

AINewsWire is powered by IBN

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Announces Bond Offering, Provides Access to Retail Investors

October 25, 2023 14:06:23

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has announced a $10 million public safety infrastructure bond offering enabling the public to fight crime with their investment portfolio.

“It is our view that retail investors are often precluded from participating in high-yield debt offerings made by publicly traded companies, and we hope to begin to address that injustice through this bond offering. Simultaneously, this can provide semi-permanent long-term growth capital in a non-dilutive form to continue to fuel Knightscope’s growth,” William Santana Li, chairman and CEO of Knightscope, was quoted in the press release.

The announcement reads, “The company is offering 10% interest, paid in cash annually, on up to a 5-year bond. For example, a $10,000 investment could yield $1,000 of interest in cash payments annually. Over 5 years, an investor could accumulate up to $5,000 in interest payments.”

To view the full press release, visit https://ibn.fm/QSL3v

About Knightscope, Inc.

Knightscope is an advanced public safety technology company that builds fully autonomous security robots and blue light emergency communications systems that help protect the places people live, work, study and visit. Knightscope’s long-term ambition is to make the United States of America the safest country in the world. For more information, visit the company’s website at www.knightscope.com.

NOTE TO INVESTORS: The latest news and updates relating to Knightscope are available in the company’s newsroom at https://ibn.fm/KSCP

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Hearings Commence for Lawsuit Denying Psilocybin Scheduling Change Request

October 25, 2023 12:20:47

A federal appeals court panel has begun hearing arguments in a case involving a Seattle doctor who sued the U.S. Drug Enforcement Administration for denying his patients access to psilocybin therapy and who is now asking the federal government to reschedule the psychedelic. The suit is part of the Seattle-based doctor’s efforts to expand psilocybin access to terminally ill patients to treat anxiety and end-of-life depression.

Psychedelics such as psilocybin, or magic mushrooms, are all the rage these days thanks to a growing body of research indicating they have…

About PsychedelicNewsWire

To receive SMS alerts from PsychedelicNewsWire, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.PsychedelicNewsWire.com

PsychedelicNewsWire
San Francisco, CA
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]

PsychedelicNewsWire is powered by IBN

China Curbs Graphite Exports, a Move That Could Hamper EV Industry

October 25, 2023 12:15:51

Last week, the Chinese Ministry of Commerce announced that it would cut graphite exports in a move that has the potential to cripple the global electric vehicle industry. With tensions between China and the United States and its allies rising in recent years, nations such as the U.S. are keen on cutting their reliance on China to limit the Asian country’s leverage in the nascent electric vehicle industry.

Battery electric vehicles (BEVs) are powered by lithium-ion batteries and produce zero emissions at the tailpipe, making them a perfect replacement for…

NOTE TO INVESTORS: The latest news and updates relating to Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) are available in the company’s newsroom at http://ibn.fm/UURAF

About MiningNewsWire

MNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from MiningNewsWire, text “BigHole” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, CA
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is powered by IBN

MiningNewsBreaks – Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) Featured in Bell2Bell Podcast

October 25, 2023 11:57:00

Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF), a company working to advance the next generation of high quality nickel sulphide projects to feed the high growth electric vehicle and stainless steel markets, was featured in the latest episode of the Bell2Bell Podcast, a part of IBN’s sustained effort to provide specialized content distribution via widespread syndication channels. Mark Selby, CEO and director of Canada Nickel, joined the latest episode to discuss the company’s projects, including its recent news announcing the positive bankable feasibility study for its Crawford Nickel Sulphide Project. “It’s a major milestone for the company – $2.5 billion after-tax NPV, 17% IRR. When you include the additional carbon capture and storage tax credits that we think we’ll be able to get, that nudges the IRR up to 18%. This is for a project that’s going to be a 40-year mine life,” Selby said. “We’re the second-largest nickel reserve in the world, the second-largest nickel resource in the world and, if we were fully ramped-up today, we’d be the third-largest nickel-sulphide operation globally.”

To view the full press release, visit https://ibn.fm/vVRao

About Canada Nickel Company Inc.

Canada Nickel is advancing the next generation of nickel- sulphide projects to deliver nickel required to feed the high-growth electric vehicle and stainless steel markets. Canada Nickel has applied in multiple jurisdictions to trademark the terms NetZero Nickel(TM), NetZero Cobalt(TM) and NetZero Iron(TM) and is pursuing the development of processes to allow the production of net-zero carbon nickel, cobalt and iron products. Canada Nickel provides investors with leverage to nickel in low political risk jurisdictions. Canada Nickel is currently anchored by its 100% owned flagship Crawford Nickel-Cobalt Sulphide Project in the heart of the prolific Timmins-Cochrane mining camp. For more information, please visit www.CanadaNickel.com.

NOTE TO INVESTORS: The latest news and updates relating to CNIKF are available in the company’s newsroom at https://ibn.fm/CNIKF

About MiningNewsWire

MNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from MiningNewsWire, text “BigHole” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, CA
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is powered by IBN

InvestorNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Issued Notice of U.S. Patent Allowance from USPTO

October 25, 2023 11:46:47

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, announced that the U.S. Patent and Trademark Office (“USPTO”) has issued a notice of allowance for the company’s patent application covering calibrating imaging devices, matching elements in stereo imaging systems and creating 3D reconstructions. According to the announcement, the patent application, which is titled “System and Method for Stereoscopic Image Analysis,” enables the generation of 3D depth perception from any pair of cameras, even those that have different optical properties and fields of view. “This capability allows for flexible cameras positioning on vehicles, and also enables vehicle manufacturers to leverage different existing cameras that could not previously be used for depth perception,” the company noted in the press release. “This technology improves obstacle detection and enhances understanding of road conditions for advanced driver-assistance system (‘ADAS’) or autonomous driving. The patented technology includes a method for automatic calibration of cameras and a computationally efficient method for calculating dense depth maps. This technology transforms a pair of cameras and a processor into a high frequency and accurate depth sensor.”

To view the full press release, visit https://ibn.fm/r5IB4

About Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings is a technology company developing smart multispectral vision software solutions and cellular-based applications. Through the company’s wholly owned subsidiaries — Foresight Automotive Ltd., Foresight Changzhou Automotive Ltd. and Eye-Net Mobile Ltd. — Foresight develops both “in-line-of-sight” vision systems and “beyond-line-of-sight” accident-prevention solutions. Foresight vision solutions include modules of automatic calibration and dense three-dimensional (“3D”) point cloud that can be applied to different markets such as automotive, defense, autonomous vehicles and heavy industrial equipment. Eye-Net Mobile’s cellular-based solution suite provides real-time, precollision alerts to enhance road safety and situational awareness for all road users in the urban mobility environment by incorporating cutting-edge AI technology and advanced analytics. For more information, visit the company’s website at www.ForesightAuto.com.

NOTE TO INVESTORS: The latest news and updates relating to FRSX are available in the company’s newsroom at http://ibn.fm/FRSX

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Europe Looks to Curb Chinese EVs, But Motorists Love Them

October 25, 2023 11:34:48

A recent influx of cheap Chinese battery electric vehicles (BEVs) into the European market has European Union leaders worried. While most nations with EV transition plans have invested in EV subsidies and incentives, China is spending much more on its domestic electric vehicle industry.

The Chinese government has invested billions of dollars into subsidizing the EV production process, allowing local automakers to price their…

About GreenCarStocks

To receive SMS alerts from GreenCarStocks, text “Green” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the GreenCarStocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

GreenCarStocks
Los Angeles, CA
www.GreenCarStocks.com
310.299.1717 Office
[email protected]

GreenCarStocks is powered by IBN

Four Marketing Channels that eCommerce Firms Can Leverage

October 25, 2023 11:14:52

In an incredibly competitive market such as e-commerce, where 90% of companies fail, marketing is key to standing out from the competition and maintaining profitability. The right marketing channel mix can help you drive traffic to your merchant sites, increase conversions and boost your virtual store’s revenue.

Although billions of people buy and sell online every year, attracting and retaining customers to a platform can be…

NOTE TO INVESTORS: The latest news and updates relating to NextPlat Corp. (NASDAQ: NXPL) are available in the company’s newsroom at https://ibn.fm/NXPL

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

BioMedNewsBreaks – Safety Shot (NASDAQ: SHOT) Granted Second U.S. Patent for JW-700 Treatment Designed for $1.5B Hair-Growth Market

October 25, 2023 11:10:21

Safety Shot (NASDAQ: SHOT), a wellness and functional beverage company, announced a “significant milestone” in its development of treatments for androgenetic alopecia, or hair loss: the granting of a second U.S. patent issued for JW-700, a topical treatment designed to improve minoxidil’s efficacy. The patent was issued by the U.S. Patent and Trademark Office. The patent adds to the growing global intellectual property (“IP”) estate for Safety Shots Legacy products. According to the announcement, minoxidil is a common treatment of hair loss sold under brand names including Rogaine(R) and Hair Regrowth for Men(R), and Safety Shot’s JW-700 has been shown to increase key enzymes needed for minoxidil to work by up to seven times over a two-week period. The company has launched the product in India, where it is exceeding sales projections, and is planning product expansion into 30 more countries through a distribution partnership with Cosmofix & San Pellegrino.

“This new, broader U.S. patent, encompassing new formulations, is a crucial component of Safety Shot’s ongoing pursuit of the $1.5 billion minoxidil hair loss market,” said Safety Shot CEO Brian John in the press release. “Following its launch in India in July of 2023, sales of MinoxiBoost have exceeded all expectations and we expect our distribution partners will continue to deliver robust sales. The recently completed clinical trial is a vital next step to support a full launch of JW-700 in the U.S. and other key markets. We look forward to reporting data in the coming weeks as well as the launch of this incredible product in the USA.”

To view the full press release, visit https://ibn.fm/cyCxb

About Safety Shot

NOTE TO INVESTORS: The latest news and updates relating to SHOT are available in the company’s newsroom at https://ibn.fm/SHOT

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

InvestorNewsBreaks – Standard Lithium Ltd. (TSX.V: SLI) (NYSE American: SLI) (FRA: S5L) Confirms Exceptional Quality of Lithium Brine Assets in East Texas

October 25, 2023 10:51:05

Standard Lithium (TSX.V: SLI) (NYSE American: SLI) (FRA: S5L), a leading near-commercial lithium company, today announced another significant milestone in its ongoing Smackover expansion efforts. As part of the company’s extensive work in East Texas, it has drilled and sampled a new highest confirmed lithium grade brine, measuring 806 mg/L. In addition, comprehensive brine analyses from all three of the company’s new wells in East Texas show highly elevated concentrations of potash (“KCl”) and bromine, representing a large potential for these commodities. “This most recent brine sample from our newest well in East Texas confirms the exceptional quality of the lithium brine assets we’re acquiring in East Texas,” said Dr. Andy Robinson, president and COO of Standard Lithium. “With a new confirmed lithium analysis of 806 mg/L and an average grade of 644 mg/L in our drilled area, we believe that we have identified a globally significant lithium brine asset. This work has been made possible by our team of Smackover experts who, over the past three years have identified the most prospective, highest quality development areas in East Texas.”

To view the full press release, visit https://ibn.fm/a5qEg

About Standard Lithium Ltd.

Standard Lithium is a leading near-commercial lithium development company focused on the sustainable development of a portfolio of lithium-brine bearing properties in the United States. The company prioritizes brine projects characterized by the highest-grade resources, robust infrastructure, skilled labor, and streamlined permitting. The company aims to achieve sustainable, commercial-scale lithium production via the application of a scalable and fully integrated direct lithium extraction (“DLE”) and purification process. The company’s flagship projects, the Phase 1A and the South West Arkansas projects, are located on the Smackover Formation in southern Arkansas near the Louisiana state line, a region with a long-standing and established brine processing industry. The company has also identified a number of highly prospective lithium brine project areas in the Smackover Formation in East Texas and began an extensive brine leasing program in the key project areas. In addition, the company has an interest in certain mineral leases located in the Mojave Desert in San Bernardino County, California. Standard Lithium trades on both the TSX Venture Exchange and the NYSE American under the symbol SLI and on the Frankfurt Stock Exchange under the symbol S5L. For more information, please visit the company’s website at www.StandardLithium.com.

NOTE TO INVESTORS: The latest news and updates relating to SLI are available in the company’s newsroom at https://ibn.fm/SLI

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Cybin Inc.’s (NEO: CYBN) (NYSE American: CYBN) Granted Two US Patents Protecting Exclusive Deuterated DMT Program

October 25, 2023 10:30:21

Cybin (NEO: CYBN) (NYSE American: CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, has been granted two patents by the United States Patent and Trademark Office; the patents offer protection for the company’s deuterated N, N-dimethyltryptamine (“DMT”) program, including deuterated analogs of DMT related to composition of matter, medical use and synthesis. According to the announcement, the company’s intellectual portfolio (“IP”) now includes of 32 granted patents along with more than 170 pending applications. The granted patents include U.S. patent no. 11,771,681, which provides composition of matter protection for certain deuterated analogs of DMT, and U.S. patent no. 11,773,062, which provides protection for the medical use and the novel, efficient and scalable synthesis of certain analogs of DMT.

The company noted that both of its proprietary novel deuterated DMT compounds, CYB004 and SPL028, are in phase I clinical trials, with initial data demonstrating that IV CYB004 and SPL028 elicit a psychedelic experience of less than one hour and are well tolerated. The company anticipates topline data readouts from both studies in Q4 2023. “Following Cybin’s recent acquisition of Small Pharma Inc., our development programs are protected by 32 granted patents and over 170 pending applications, establishing our leadership position in developing novel tryptamine-based therapeutics in a key market,” said Cybin CEO Doug Drysdale in the press release. “This multilayered and robust IP protection includes composition of matter, medical use, synthesis and drug-product protection, providing us with the latitude to advance our deuterated programs with confidence.”

To view the full press release, visit https://ibn.fm/wa2D4

About Cybin Inc.

Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental-health conditions. Cybin’s goal of revolutionizing mental healthcare is supported by a network of world-class partners and internationally recognized scientists aimed at progressing proprietary drug-discovery platforms, innovative drug-delivery systems, and novel formulation approaches and treatment regimens. The company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder, and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder; the company also has a research pipeline of investigational psychedelic-based compounds. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland. For more information, visit the company’s website at www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

MiningNewsBreaks — Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) (FSE: HF2) Notes Increase of Nonbrokered Offering

October 25, 2023 10:13:30

Reflex Advanced Materials (CSE: RFLX) (OTCQB: RFLXF) (FSE: HF2), a mineral exploration company, has upsized its nonbrokered private placement financing, which had been announced initially in August. The first two tranches of the offering closed earlier this month, and the offering now consists of up to 7,500,000 units of the company offered at $0.20 per unit, resulting in an anticipated $1.5 million gross proceeds; the original projection was for $1 million. According to the announcement, each unit of the offering includes one common share in the capital of the company and one-half of one share purchase warrant, with each whole warrant entitling the holder to purchase an additional share at an exercise price of $0.35 for a period of 24 months from the date of issuance. The announcement noted that closing of the offering is anticipated prior to Nov. 6, 2023, and is dependent on certain conditions and approvals. Reflex Advanced Materials anticipates using the gross proceeds from the offering to advance its Ruby Graphite Project along with other general corporate purposes.

To view the full press release, visit https://ibn.fm/Byx3T

About Reflex Advanced Materials Corp.

Reflex Advanced Materials is a mineral exploration company based in British Columbia. Its objective is to locate and, if warranted, develop economic mineral properties in the strategic metals and advanced materials space. The company is focused on improving domestic specialty mineral infrastructure efficiencies to meet surging national demand by North American manufacturers. The company is also working to advance its Ruby Graphite Project, located in Beaverhead County, Montana, and ZigZag Property, located in Thunder Bay Mining Division, Crescent Lake Area, Ontario. For more information about the company, visit www.ReflexMaterials.com.

NOTE TO INVESTORS: The latest news and updates relating to RFLXF are available in the company’s newsroom at https://ibn.fm/RFLXF

About MiningNewsWire

MNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from MiningNewsWire, text “BigHole” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, CA
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is powered by IBN

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Enters Agreements for Private Placement, Preferred Investment Options

October 25, 2023 09:52:44

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, has entered into a definitive agreement for the issue and sale of more than 3 million common shares, or prefunded warrants in lieu thereof. Specifically, the company agreed to a private placement of 3,012,049 common shares priced at $0.83 per share. In addition, the company entered an agreement for an associated preferred investment option as well as a definitive agreement regarding specific outstanding preferred investment options issued in November 2022. The announcement outlines specifics of the agreement. The company also stated that the preferred investment option to be issued will be exercisable immediately upon issuance; exercise price for the offerings will be $0.83 per share, with an expiration date five and one-half years from the date of issuance. InMed Pharmaceuticals is projected to receive approximately $5.2 million in net proceeds from the offerings, before standard deductions and expenses; the offerings should close on or about Oct. 26, 2023, subject to customary closing conditions being met. InMed Pharmaceuticals anticipates using the net proceeds to continue pipeline development of its pharmaceutical drug candidates and to fund commercial sales of rare cannabinoids. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offerings.

To view the full press release, visit https://ibn.fm/lgY9v

About InMed Pharmaceuticals Inc.

NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://ibn.fm/INM

About TinyGems

TinyGems is a specialized communications platform with a focus on innovative small-cap and mid-cap companies with bright futures and huge potential. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TinyGems is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, TinyGems brings its clients unparalleled recognition and brand awareness. TinyGems is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from TinyGems, text “Gems” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.TinyGems.com

Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer

TinyGems
Los Angeles, CA
www.TinyGems.com
310.299.1717 Office
[email protected]

TinyGems is powered by IBN

Australian Treasury Wants to Regulate Crypto Exchanges

October 25, 2023 09:35:00

The Australian government is pushing ahead with its efforts to oversee the crypto asset industry, specifically focusing on regulating crypto exchanges, a move that would possibly require the government to secure a license from the nation’s financial regulatory authority. The Australian Treasury unveiled a consultation paper, titled “Regulating crypto-asset platforms,” on Oct. 16, 2023, outlining a regulatory framework that aims to not only safeguard consumers but also foster innovation in the digital asset industry.

The main idea behind the new framework is to control crypto exchanges and service providers rather than the actual tokens or cryptocurrencies. Furthermore, rather than creating new regulations unique to…

About CryptoCurrencyWire

To receive SMS alerts from CryptoCurrencyWire, text “CRYPTO” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.CryptoCurrencyWire.com

CryptoCurrencyWire
New York, NY
www.CryptoCurrencyWire.com
212.994.9818 Office
[email protected]

CryptoCurrencyWire is powered by IBN

Clene Inc. (NASDAQ: CLNN) Announces Four-Year Grant to Support Expanded Access Protocol for CNM-Au8 From NINDS

October 25, 2023 09:05:00

Clene’s wholly-owned subsidiary, Clene Nanomedicine Inc., in collaboration with Columbia University and Synapticure, has been awarded a four-year grant totaling $45.1 million from the National Institute of Neurological Disorders and Stroke (“NINDS”)
The study will monitor safety, survival, clinical worsening, and key disease progression-related biomarkers while using CNM-Au8
Research conducted by Clene estimates that ALS is the most prevalent adult-onset progressive motor neuron disease, affecting approximately 30,000 people in the US and an estimated 500,000 people worldwide, with a life expectancy of diagnosed patients typically ranging from three to five years

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company on a mission to transform the treatment of neurodegenerative diseases, recently announced that its wholly-owned subsidiary Clene Nanomedicine Inc., in collaboration with Columbia University and Synapticure, has been awarded a four-year grant totaling $45.1 million from the National Institute of Neurological Disorders and Stroke (“NINDS”). The grant will support an Expanded Access Protocol (“EAP”) for Clene’s investigational drug, CNM-Au8(R), for amyotrophic lateral sclerosis (“ALS”). The grant is supported by the National Institute of Health (“NIH”) grant U01NS136023 (https://ibn.fm/03fnZ).

An EAP, also called “Compassionate Use,” is an FDA-regulated pathway that allows people with serious and life-threatening diseases to access investigational drugs that have not yet been approved by the US Food and Drug Administration (“FDA”). In addition to the EAP, Clene plans to continue its current…

NOTE TO INVESTORS: The latest news and updates relating to CLNN are available in the company’s newsroom at https://ibn.fm/CLNN

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

DGE 3rd Investigator Initiated Trials Summit 2023: Unlocking Innovations in Pharma Research and Collaboration

October 25, 2023 08:50:00

The 3rd Investigator Initiated Trials Summit will be held on November 13-14, 2023 in Philadelphia. The DGE event is focused on exploring the most lucrative ways for reviewing, selecting, and funding research investigators. Researchers, medical officers, health and pharma executives and companies can harness the reach and network of the DGE platform to connect with industry stalwarts and discuss vital issues on how they effectively manage IITs.

The speakers will offer important insights on ways to leverage the new methods for new indications, label expansion and potential publications. The conference aims to create a bridge between pharma suppliers and sponsors who are providing vital data and real-world evidence while remaining…

To know more, please visit https://ibn.fm/AOeXP

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

420 with CNW — Five Years On, Stigma About Marijuana Still Persists in Canada

October 25, 2023 03:25:00

Canada legalized recreational cannabis in October 2018 via the Cannabis Act and allowed the cultivation, production, import, export, distribution, purchase, sale and consumption of recreational cannabis by legal adults. The country’s cannabis industry reached $4.4 billion in value in 2022 and is expected to hit $7.7 billion by 2026.

However, even though around 27% of the population has reportedly used cannabis in the past 12 months and recreational cannabis has been legal for…

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is powered by IBN

420 with CNW — Marijuana Wholesalers Opt for Island-Hopping in Hawaii

October 24, 2023 15:25:00

Several medical cannabis companies in Hawaii have pioneered a new sales route in the state that involves delivering wholesale cannabis flower and other cannabis products from one island to another. Hawaii legalized medical cannabis in 2000 via the state legislature and has only eight licensed medical marijuana dispensaries scattered across the archipelago.

The island state’s unique topography may have allowed for the growth of this new sales route as medical marijuana businesses strived to…

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is powered by IBN

InvestorNewsBreaks – Tingo Group Inc. (NASDAQ: TIO) Enters MOU to Launch Business, Service Offerings in Pakistan

October 24, 2023 13:20:04

Tingo Group (NASDAQ: TIO), a profitable and fast growing fintech, agri-fintech, food and commodity trading company, today announced that it has executed a memorandum of understanding (“MOU”) with the Khyber Pakhtunkhwa Information Technology Board (“KPITB”) to launch the company’s business and service offerings into Pakistan. KPITB is a governmental body established in the province of the Khyber Pakhtunkhwa, Pakistan, for the promotion of information technology for the public and private sector. “As we look to introduce and replicate our successful business model in new geographical markets and accelerate growth, we are delighted to have this opportunity to establish a dominant position in the fifth most populous country in the world and one of the largest agricultural markets.

Moreover, we are honored to have the KPITB and government of Pakistan as a strategic partner in this remarkable opportunity,” said Dozy Mmobuosi, interim co-chief executive officer of Tingo Group. “The MOU allows us to roll out all of the main areas of our existing ecosystem in Pakistan including our fintech, agri-fintech and marketplace platforms such as Nwassa and TingoPay, as well as our food processing business and commodity trading and export business. Similar to Nigeria when we launched Nwassa there in 2020, Pakistan’s productivity levels in agriculture are relatively low and post-harvest losses are high despite the large percentage of its sizeable population being employed in the sector. These conditions, combined with the superior communications and logistics infrastructures compared to Nigeria, provide us with considerable scope to further deliver upon our mission goals and objectives of increasing food production levels and tackling the world’s food security crisis.”

To view the full press release, visit https://ibn.fm/Tz5lx

About Tingo Group Inc.

Tingo is a global fintech, agri-fintech, food processing and commodity trading group of companies with operations in Africa, Southeast Asia and the Middle East. Tingo Group’s wholly owned subsidiary, Tingo Mobile, is a leading agri-fintech company operating in Africa, with a comprehensive portfolio of innovative products, including a “device-as-a-service” smartphone and a value-added service platform, the cornerstone of which is the Nwassa “seed-to-sale” marketplace platform, as well as insurance, micro-finance and mobile phone and data top-up. Tingo Group’s other business verticals include: TingoPay, a super app in partnership with Visa, offering a wide range of B2C and B2B services including payment services, an e-wallet, foreign exchange and merchant services; Tingo Foods, a food processing business that processes raw foods into finished products such as rice, groundnut oil, nut products, wheat, millet and maize; and Tingo DMCC, a commodity trading platform and agricultural commodities export business based out of the Dubai Multi Commodities Center. In addition to its Tingo business verticals, Tingo Group also holds and operates an insurance brokerage platform business in China; and Magpie Securities, a regulated finance services fintech business operating out of Hong Kong and Singapore, which, as relatively small businesses within the company, are currently in the process of being reviewed and re-positioned. For more information about the company, visit www.TingoGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to TIO are available in the company’s newsroom at https://ibn.fm/TIO

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Why Some People Get Anxious After Taking Psilocybin Mushrooms

October 24, 2023 11:49:52

Advances in psychedelic research have found that psilocybin mushrooms may be able to treat mental conditions such as depression, cancer-related psychological stress and substance use disorders. Psilocybin-assisted therapy typically involves going through a guided psilocybin experience and using talk therapy to integrate the insights and realizations made during the experience into everyday life.

This kind of treatment has proven that it can alleviate mental disorders including depression, but many patients aren’t keen on going through what might be…

About PsychedelicNewsWire

To receive SMS alerts from PsychedelicNewsWire, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.PsychedelicNewsWire.com

PsychedelicNewsWire
San Francisco, CA
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]

PsychedelicNewsWire is powered by IBN

Whitehaven to Buy Mitsubishi, BHP Coal Mines at $4.1B

October 24, 2023 11:42:57

Australian coal operator Whitehaven Coal will purchase two coal mines in Queensland from Mitsubishi and BHP Group, totaling $4.1 billion. BHP Group and Mitsubishi controlled the two mines through an equally owned joint venture and announced the sale after posting a close to 4% drop in iron ore output. The sale occurred at an auction that saw Whitehaven, currently the largest listed miner on the globe, scoop up the Blackwater and Daunia metallurgical coal mines.

According to Mitsubishi, the deal was set at $3.2 billion, with the additional $900 million being paid over a three-year period under…

NOTE TO INVESTORS: The latest news and updates relating to Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) are available in the company’s newsroom at http://ibn.fm/CNIKF

About MiningNewsWire

MNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from MiningNewsWire, text “BigHole” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, CA
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is powered by IBN

MiningNewsBreaks – International Mining and Resources Conference 2023 Agenda Has ‘Something for Everyone’

October 24, 2023 11:36:39

The International Mining and Resources Conference (“IMARC”) is forecast to be the largest ever, with mining and resource leaders coming from around the world. The three-day event is slated for Oct. 31–Nov. 2, 2023, and will be held in Sydney. This year’s agenda features more than 520 speakers and 120-plus exhibitors. Expert presenters come from global giants such as BHP, Fortescue, MMG, Gold Fields, Wesfarmers, Worley, Perenti, IGO, the U.S. Departments of Energy and Defense, and the ICMM. Speakers and presentations will include topics such as Digital Transformation and Innovation; Sustainability, Social Value, Environmental Resilience, People and Culture; Trade, Investment and Project Opportunities; and Energy Transition.

The conference will also include the IMARC NextGen Program, which is designed to give 200 schoolchildren an opportunity to learn about the diverse and exciting mining and resources industry. In addition, the 2023 event includes a special ESG focus on creating social value; an extensive look at First Nations engagement, human rights and transparency; a look at best-practice mine rehabilitation; global perspectives on heritage and environmental custodianship and economic development; and a return of the successful Balance for Better Program, which promotes equality, diversity and inclusion across all areas of the mining and resources sector.

“The mining and resources industry is evolving rapidly to meet the growing energy demands of today while developing the minerals needed for a decarbonized economy — under unprecedented scrutiny from communities, regulators and investors,” said IMARC chief operating officer Anita Richards in the press release. “IMARC 2023 comes at a time when explorers and miners are diversifying portfolios to align with future demand, triggering the highest level of M&A activity across both mining and METS we have ever seen. . . . Mining and resources have never been more important for sustainable economic, social and innovative development across the globe. We need more exploration and development to match surging demand for the critical minerals that are central to the global energy transition. IMARC 2023 is where the most important conversations are being held about how mining and resources can help achieve global development sustainably and equitably.”

To view the full article, visit https://ibn.fm/rzEGg

About the International Mining and Resources Conference

The International Mining and Resources Conference (IMARC) is where global mining leaders collaborate on trends in mining, investment and innovation toward a sustainable future. As Australia’s largest mining event, it brings together more than 8,500 decision makers, mining leaders, policy makers, investors, commodity buyers, technical experts, innovators and educators from more than 100 countries for three days of learning, deal making and unparalleled networking. IMARC is developed in collaboration with its founding partners the Victorian State Government, Austmine, the Australasian Institute of Mining and Metallurgy (AusIMM) and Mines and Money, and held with the support of its host partner, the New South Wales government. For more information about this event, please visit www.IMARCGlobal.com

About MiningNewsWire

MNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from MiningNewsWire, text “BigHole” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, CA
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is powered by IBN

InvestorNewsBreaks – HyperSense Software Expands Footprint to Bring Innovative Solutions to the Windy City

October 24, 2023 11:32:43

HyperSense, a renowned global provider of software development and digital transformation solutions, today announced the opening of its new office in Chicago, marking a significant expansion in its U.S. presence. The move demonstrates HyperSense’s commitment to bringing its unparalleled expertise closer to clients in diverse industries including fintech, health care, e-learning, manufacturing and IT/software. The expansion comes on the heels of HyperSense’s continued recognition with several “Top Development Company” awards from Clutch and prestigious membership in the Forbes Business Council. “Chicago is a vibrant hub of innovation and business growth,” said Andrei Neacsu, CTO of HyperSense. “We are thrilled to join this dynamic ecosystem, bringing our unique blend of technical proficiency and creative problem-solving to help local businesses thrive in the digital age.”

To view the full press release, visit https://ibn.fm/h5feg

About HyperSense Software

HyperSense is a globally recognized software development company with two decades of experience in delivering transformative digital solutions. The company holds several awards and ISO Certifications and is a member of the Forbes Business Council. HyperSense is committed to innovation, quality and creating lasting partnerships with its clients. For more information, visit HyperSense.

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Advance INM-901 Following Positive Proof-of-Concept Results

October 24, 2023 11:26:51

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announced its selection of a lead Alzheimer’s disease drug candidate, named INM-901, following positive results from several proof-of-concept studies in a validated Alzheimer’s treatment model. InMed will be advancing cannabinoid analog INM-901 in its pharmaceutical drug development program. “The most recent studies of INM-901 demonstrate promising disease-modifying effects in an Alzheimer’s disease treatment model,” said Dr. Eric Hsu, InMed’s SVP of preclinical research and development. “We are optimistic that the next stage of studies will continue to show how this cannabinoid analog can improve neuronal function, a potential breakthrough in Alzheimer’s treatment. Alzheimer’s disease patients have had limited treatment options until recently and while there have been advancements in understanding disease pathology, there are major limitations to current therapies. There remains a huge unmet medical need for this progressive disease that takes a major toll on patients and their families.”

To view the full press release, visit https://ibn.fm/7lffw

About InMed Pharmaceuticals Inc.

NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://ibn.fm/INM

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN; LGVNR) Top-Line Results from Phase 2a Trial Spotlighted in Latest NNA Release

October 24, 2023 11:12:02

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty, is featured in a recent NetworkNewsAudio (“NNA”) broadcast. The segment focuses on the company’s most recent announcement of its topline results from the CLEAR Mind phase 2a clinical trial of LGVN’s Lomecel-B(TM) for the treatment of mild Alzheimer’s disease. According to the segment, the Lomecel-B study met its primary safety endpoint and is supported by lack of deterioration in cognitive or atrophy signals. The encouraging results will be used as a foundation for further studies, the company noted. NNA segments are designed to bring a company additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points.

The audio news release covers Longeveron’s recent news regarding positive top-line results from its phase 2a trial of its investigational product Lomecel-B(TM) for the treatment of mild Alzheimer’s disease. “We believe these results provide important validation of both the safety and therapeutic potential of Lomecel-B in the treatment of Alzheimer’s disease and provide a robust foundation for additional clinical trials in this and other indications,” said Longeveron CEO Wa’el Hashad in the news release. “We look forward to announcing additional biomarker data from this trial, anticipated to be later this month, which may further characterize the clinical effects of Lomecel-B in this study population. With our phase 2 ELPIS II trial in HLHS moving toward anticipated completion in 2024, and our phase 2 program in Aging-Related Frailty progressing in Japan as well, we look forward to meaningful milestones in the near term and to fully realizing the therapeutic potential of Lomecel-B.”

To hear the audio production, visit https://ibn.fm/AOoJ8

To view the full press release, visit https://ibn.fm/xVlTo

About Longeveron Inc.

Longeveron is a clinical-stage, biotechnology company developing regenerative medicines to address unmet medical needs. The company’s lead investigational product is Lomecel-B(TM), an allogeneic medicinal signaling cell (“MSC”) therapy product isolated from the bone marrow of young, healthy adult donors. Lomecel-B has multiple potential mechanisms of action encompassing provascular, proregenerative, anti-inflammatory, and tissue repair and healing effects with broad potential applications across a spectrum of disease areas. Longeveron is currently advancing Lomecel-B through clinical trials in three indications: hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty. To learn more about the company, visit www.Longeveron.com.

NOTE TO INVESTORS: The latest news and updates relating to LGVN are available in the company’s newsroom at https://ibn.fm/LGVN

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

InvestorNewsBreaks – Playgon Games Inc. (TSX.V: DEAL) (OTC: PLGNF) (FSE: 7CR) Announces Q3 Player Activity Milestones

October 24, 2023 11:01:06

Playgon Games (TSX.V: DEAL) (OTC: PLGNF) (FSE: 7CR), a SaaS technology company delivering innovative mobile live dealer technology to online gaming operators globally, today announced key milestones for Q3 2023 ending in September. Among the highlights, the company announced that its player activity continues to scale at its live dealer tables since last quarter. Playgon’s quarterly wagering turnover increased to $449,000,000, a 10% increase from $409,000,000 in Q2 2023. “Our sales and integration pipeline continues to be strong, and our business continues to scale,” said Darcy Krogh, CEO of Playgon Games Inc. “The industry remains strong and Playgon is well positioned to participate in the ongoing growth. We look forward to announcing new games, new markets and new partnerships soon.”

To view the full press release, visit https://ibn.fm/6YUbj

About Playgon Games Inc.

Playgon is a SaaS technology company focused on developing and licensing digital content for the growing iGaming market. The company provides a multitenant gateway that allows online operators the ability to offer their customers innovative iGaming software solutions. Its current software platform includes Live Dealer Casino, E-Table games, which, through a seamless integration at the operator level, allows customer access without having to share or compromise any sensitive customer data. As a true business-to-business digital content provider, the company’s products are ideal turnkey solutions for online casinos, sportsbook and land-based operators, media groups, and big database companies. For further information, please visit the company’s website at www.Playgon.com.

NOTE TO INVESTORS: The latest news and updates relating to PLGNF are available in the company’s newsroom at https://ibn.fm/PLGNF

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

MiningNewsBreaks – GEMXX Corporation (GEMZ) Releases Gold Production Report for BC-Based Snow Creek Test Mine Site

October 24, 2023 10:49:38

GEMXX (OTC: GEMZ), a leader in the ammolite gemstone mine-to-market segment and a 50% partner in Canadian gold-exploration company Crazy Horse Mining Inc. (“CHMI”), has successfully completed its third and final clean-out and recording of gold production at the Snow Creek Mine site for the 2023 mining season. According to the announcement, GEMXX and CHMI have processed 31,200 cubic yards of gold-bearing ore during the 2023 test season; those results met all expectations, the report noted, and are positive considering much of the material used during the test program was surface “gold bearing ore” that had been stockpiled when making roads, ponds and pads used for the test site. A Canadian junior resource company, CHMI operates mining properties in British Columbia, Canada, including the Rosella Creek and Snow Creek claims.

The two companies are evaluating moving the test plant from Snow Creek to the adjacent Rosella Creek property to confirm the gold on that property in 2024; they are also studying the most effective way to scale up operations on the Snow Creek property to maximize the property’s commercial potential. “Gold production from the Snow Creek mine helps to derisk revenues, but most importantly, it complements our ammolite production with the world’s most sought-after commodity,” said GEMXX CEO Jay Maull in the press release. “Producing our own gold provides GEMXX with a significant reduction in the cost of goods for our entire gold jewelry product line, bringing the company one step closer to our goal of becoming vertically integrated.”

To view the full press release, visit https://ibn.fm/fBK9s

About GEMXX Corporation

GEMXX is a publicly traded, mine-to-market gemstone, gold and jewelry producer with global reach that owns mining resources, production facilities and operating assets. GEMXX controls each stage of its production including gold mining, gemstone production, jewelry manufacturing and global distribution. GEMXX is a producer of top-quality finished ammolite and ammolite jewelry. The company’s world-class gemstone cutters and jewelry designers are continuously leading the ammolite industry in new and exciting directions. The company’s management team is made up of the industry’s leading experts with a combined total of 160 years of ammolite gemstone and jewelry business experience. For more information about this company, please visit www.GEMXX.com.

NOTE TO INVESTORS: The latest news and updates relating to GEMZ are available in the company’s newsroom at https://ibn.fm/GEMZ

About MiningNewsWire

MNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from MiningNewsWire, text “BigHole” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, CA
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is powered by IBN

InvestorNewsBreaks – Siyata Mobile Inc. (NASDAQ: SYTA), Synch Collaborate to Provide Emergency Response Solutions in Israel

October 24, 2023 10:31:28

Siyata Mobile (NASDAQ: SYTA), a global developer and vendor of push-to-talk over cellular (“PoC”) handsets and accessories, today announced that it is partnering with Synch Communication to provide essential communication solutions for first responders in Israel. According to the announcement, the arrangement integrates the Synch application for communication, command and control with Siyata’s SD7 handsets to enhance the capabilities of push-to-talk (“PTT”) in emergency environments. “We are proud to partner with Synch to provide our innovative mission critical push-to-talk SD7 handset with its state-of-the-art command and control platform,” said Marc Seelenfreund, CEO of Siyata. “With Synch’s robust platform, our handsets, which are well-suited for emergency response, enable instant communication for first responders. Together, our solutions are helping first responders in Israel to do their job more efficiently, and save lives, which is as important now as it has ever been.”

To view the full press release, visit https://ibn.fm/kYUs4

About Siyata Mobile Inc.

NOTE TO INVESTORS: The latest news and updates relating to SYTA are available in the company’s newsroom at https://ibn.fm/SYTA

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Partners with Lincare in New Nationwide Distribution Deal

October 24, 2023 10:13:38

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from a variety of health conditions, many of which are associated with breathing-related sleep conditions arising from certain dentofacial abnormalities, has signed a U.S. nationwide distribution agreement with Lincare. The two companies have been involved in a distribution pilot program, and the agreement follows the success of that program. According to the announcement, the agreement, which gives Lincare exclusive rights to distribute certain Vivos devices for the next six months, is “an important milestone” for the company as it focuses on engaging with leading durable medical equipment (“DME”) companies across the country. Lincare is a leading supplier of in-home respiratory therapy products and services for approximately 1.8 million patients.

“Across the United States, hundreds of thousands of new CPAP units are rented or sold through DME companies each month,” said Vivos chair and CEO Kirk Huntsman in the press release. “Lincare is one of the market leaders in this sector, and we are pleased to join forces with them in this pioneering initiative. It is well known that a sizable number of sleep apnea patients discontinue CPAP usage in search of alternative treatment options. This important collaboration between a national supplier of DME like Lincare and an innovative oral appliance company like Vivos will bring fresh solutions and relief to patients currently seeking alternatives. Our pilot trial allowed both parties time to work through the program logistics, including the development of a new Vivos proprietary software to manage DME patients and scale to a national level. . . . As we move forward, we see these types of agreements as a key component in Vivos’ quest to achieve positive cash flows over the next year. We are currently focused on extending the scope of our efforts with Lincare to the next five major markets, with additional markets to follow according to a rollout schedule over the next 6 to 12 months.”

To view the full press release, visit https://ibn.fm/QStm0

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as mild-to-moderate obstructive sleep apnea (“OSA”) and snoring in adults. The Vivos Method represents the first clinically effective, nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution for treating mild to moderate OSA. It has proven effective in the treatment of more than 40,000 patients worldwide by more than 1,800 trained dentists. The Vivos Method includes the Vivos Complete Airway Repositioning and/or Expansion (“CARE”) appliance therapy and associated protocols that alter the size, shape and position of the soft tissues that comprise a patient’s upper airway and palate. The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild to moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos Integrated Practice (“VIP”) program offers dentist training and other value-added services in connection with using the Vivos Method. For more information about this company, visit www.Vivos.com.

NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

MiningNewsBreaks – Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) (FSE: HF2) Executes Initial Drill Program at Ruby Graphite Project

October 24, 2023 10:09:42

Reflex (CSE: RFLX) (OTCQB: RFLXF) (FSE: HF2) today announced completion of its 2023 phase one drill program at its Ruby Graphite Project near Dillon, Montana. The program’s impressive efficiencies allowed the company to complete 22 holes, surpassing the originally planned 16 holes, with all reaching an average depth of 150 meters. The company’s geological team is now focused on data compilation, with assay results expected in the first quarter of 2024. “The team is very pleased with how much we have been able to accomplish during phase one of our drill program,” said Paul Gorman, CEO of Reflex Advanced Materials. “We tested multiple conductivity anomalies along major trend and have already highlighted areas to prioritize for follow up. The affordability of drilling on this property as well as low mobilization cost has allowed the team to gather significant geological information with limited capital spent and allowed for more diamond drill holes than originally planned and budgeted for. Overall, a very efficient program was executed.”

To view the full press release, visit https://ibn.fm/kX6Mw

About Reflex Advanced Materials Corp.

Reflex Advanced Materials is a mineral exploration company based in British Columbia. Its objective is to locate and, if warranted, develop economic mineral properties in the strategic metals and advanced materials space. It is focused on improving domestic specialty mineral infrastructure efficiencies to meet surging national demand by North American manufacturers. The company is working to advance its Ruby Graphite Project, located in Beaverhead County, Montana, and ZigZag Lake Lithium Property, located in Thunder Bay Mining Division, Crescent Lake Area, Ontario. For more information, please review the company’s filings available at www.SEDAR.com.

NOTE TO INVESTORS: The latest news and updates relating to RFLXF are available in the company’s newsroom at https://ibn.fm/RFLXF

About MiningNewsWire

MNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from MiningNewsWire, text “BigHole” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, CA
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is powered by IBN

CryptoNewsBreaks – Diamond Lake Minerals Inc. (DLMI) Announces E! TV Founder as Newest Strategic Advisor, Becomes IBN Client Partner

October 24, 2023 09:33:05

Diamond Lake Minerals (OTC: DLMI), a leading multistrategy operating company specializing in the development and support of digital assets and SEC-registered security tokens, has named a new strategic advisor: Larry Namer. Renowned for his influential contributions to cable television, live events, music and new media, Namer brings an impressive five decades of experience to his new responsibilities, including cofounding E! Entertainment Television. According to the announcement, he was the visionary behind Comspan Communications, a company he founded that played a fundamental role in introducing Western forms of entertainment to the former Soviet Union; Steeplechase Media, which was the primary consultant to Microsoft’s MiTV, contributing to the development of cutting-edge interactive TV applications; and Metan Global Entertainment Group, where he led key initiatives to create and distribute content tailored for Chinese-speaking audiences in both China and across the globe. He has served as an executive producer on several projects and, in partnership with DLMI, founded the NFTYS, an award show slated for its inaugural broadcast in January 2024 and designed to be the Oscars of the Metaverse.

“We are privileged to have Larry Namer join our advisory board,” said Diamond Lake Minerals CEO Brian J. Esposito in the press release. “Larry’s unmatched experience and vision in the entertainment industry align seamlessly with our mission at Diamond Lake Minerals. He will play a pivotal role in guiding us as we continue to innovate and expand our footprint in the digital asset and security token space. Nobody knows entertainment and media better than Mr. Namer, and it’s that media component that is going to be so important in not only the entities and projects we support but also educating global audiences on security tokens and the future they hold inside investor portfolios. Larry’s commitment to excellence is evident, and we look forward to a fruitful collaboration.”

In addition, Diamond Lake Minerals announced that it has become a client partner of IBN, a multifaceted financial news and publishing company. DLMI has selected IBN to deliver key corporate communications initiatives. The company will benefit from IBN’s investor-based distribution network of more than five thousand syndication outlets, various newsletters, social media channels, wire services, blogs and other outreach tools — all designed to broaden awareness and recognition.

To view the full press releases, visit https://ccw.fm/GjpLC and https://ccw.fm/xSTvP

About Diamond Lake Minerals Inc.

Founded in Utah in 1954, Diamond Lake Minerals is a multistrategy operating company that specializes in the development and support of digital assets and SEC-registered security tokens. The company’s goal is to responsibly innovate and develop valuable traditional businesses and successfully combine them with the future of money: digital assets. DLMI’s mission is to bring back to the public markets timeless business principles that are focused on healthy sustainable growth and strong earnings that generate yields combined in a modern digital world creating value for our stakeholders. DLMI is positioning itself as an industry agnostic leader in the digital asset and security token space. For more information, visit the company’s website at www.DiamondLakeMinerals.com.

About CryptoCurrencyWire

To receive SMS alerts from CryptoCurrencyWire, text “CRYPTO” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.CryptoCurrencyWire.com

CryptoCurrencyWire
New York, NY
www.CryptoCurrencyWire.com
212.994.9818 Office
[email protected]

CryptoCurrencyWire is powered by IBN

InvestorNewsBreaks – CISO Global Inc. (NASDAQ: CISO) to Present at Upcoming MicroCap Rodeo Virtual Conference

October 24, 2023 09:22:47

CISO Global Inc. (NASDAQ: CISO), an industry leader as a managed cybersecurity and compliance provider, today announced that its CEO David Jemmett will present a corporate overview at the Fall Foliage MicroCap Rodeo. The four-day event, designed for money managers and investors by money managers and investors, is slated to take place virtually from Oct. 24 – 27, 2023. Interested parties should visit https://ibn.fm/evD7B to register for and log into the event. A live webcast of the presentation can be accessed via the investors section of the CISO website. Jemmett will be available for one-on-one meetings throughout the conference.

To view the full press release, visit https://ibn.fm/HY3Jn

About CISO Global Inc.

CISO Global, based in Scottsdale, Arizona, is an industry leader as a managed cybersecurity and compliance provider. The company is rapidly expanding by acquiring world-class cybersecurity, secured managed services, and compliance companies with top-tier talent that utilize the latest technology to create innovative solutions to protect the most demanding businesses and government organizations against continuing and emerging security threats and compliance obligations. For more information about the company, visit www.CISO.inc.

NOTE TO INVESTORS: The latest news and updates relating to CISO are available in the company’s newsroom at https://ibn.fm/CISO

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Electronic Servitor Publication Network Inc.’s (XESP) Focused Approach to Creating Profitable Customer Interactions

October 24, 2023 08:50:00

XESP, a market disruptor for B2B companies, is offering businesses a way to create digital customer interactions that pay off
Powered by its Digital Engagement Engine(TM), XESP is helping businesses avoid wastefulness while also achieving growth through its four-pronged approach
With its proprietary smart tools and technologies, the company offers value to its clients, allowing them to reach their customers at the right moment- when they need the client’s product or service
XESP is completely focused on the global customer engagement solutions market, projected to hit $32.2 billion in revenue by 2027, while also asserting itself as a leader in its segment

Electronic Servitor Publication Network (OTCQB: XESP), a market disruptor for B2B companies using cutting-edge data analysis and smart technology, is staying ahead of the curve, leveraging new and more efficient ways for businesses to drive engagement, reach bigger audiences, and build authority and credibility in their spaces. Its approach has earned it recognition from growth-focused companies and from investors.

XESP has been quick to identify inefficiencies and then provide viable and effective solutions. By focusing on eliminating wastefulness, driving growth, and helping modern businesses thrive in the evolving digital space, the company is asserting its position as a technology leader. Its revolutionary Digital Engagement…

NOTE TO INVESTORS: The latest news and updates relating to XESP are available in the company’s newsroom at https://ibn.fm/XESP

About TechMediaWire

To receive SMS alerts from TechMediaWire, text “TECH” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Los Angeles, CA
www.TechMediaWire.com
310.299.1717 Office
[email protected]

TechMediaWire is powered by IBN

BYD Reports High Q3 EV Profits as Sales Surge

October 24, 2023 08:49:44

Chinese electric vehicle giant BYD expects its net profits for third quarter 2023 to nearly double, thanks to a recent surge in electric vehicle sales. The Berkshire Hathaway-backed company is Tesla’s top competitor in China and outpaced the American EV maker by nearly 200,000 units in sales.

Forecasts from BYD show that the company predicts to record a net profit of $1.31 to $1.57 billion for the July to September period, representing a…

About GreenCarStocks

To receive SMS alerts from GreenCarStocks, text “Green” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the GreenCarStocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

GreenCarStocks
Los Angeles, CA
www.GreenCarStocks.com
310.299.1717 Office
[email protected]

GreenCarStocks is powered by IBN

Spanish Clinical Trial to Explore Marijuana as Glioblastoma Treatment

October 24, 2023 08:39:41

A major marijuana company has announced that it will begin supplying cannabis to a Spanish clinical trial investigating marijuana’s potential as a glioblastoma treatment. Tilray Brands subsidiary Tilray Medical will sponsor an upcoming clinical study to test whether marijuana can treat glioblastoma, one of the hardest-to-treat types of brain cancer.

The study will be conducted by Complutense University of Madrid and Spanish Neuro-Oncology Research Group (GEINO) scientists at…

NOTE TO INVESTORS: The latest news and updates relating to CNS Pharmaceuticals Inc. (NASDAQ: CNSP) are available in the company’s newsroom at https://ibn.fm/CNSP

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) Provides Update on Drill Program; Announces Low-Dilutive Capital Raise

October 24, 2023 08:05:00

Prospera Energy recently provided an update on the second phase of the company’s restructuring plan
With its initial five horizontal wells and incremental crude production tracking ahead of expectations, Prospera have announced plans to continue their second phase beyond its initially mooted ten well program
The company has now announced that it will proceed with a low dilutive capital raise of $3 million, with proceeds destined to fund the exploration company’s ongoing capex

Prospera Energy (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B), a public oil and gas exploration, exploitation and development company focusing on conventional oil and gas reservoirs in Western Canada, recently provided the market with an update on the second phase of its restructuring program. Boasting a business model centered around optimizing hydrocarbon recovery from legacy fields through innovative production practices and seeking to exploit the over 42,000 cumulative acres of territory across the company’s core assets, Prospera designed its second phase around drilling 10 horizontal well locations at its Cuthbert and Hearty Hills properties.

The second phase of Prospera Energy’s program has quickly advanced beyond initial expectations, with the company having already successfully drilled five horizontal wells of its multi-well infill horizontal development program (https://ibn.fm/Najtv). Prospera further revealed that with two of its…

NOTE TO INVESTORS: The latest news and updates relating to GXRFF are available in the company’s newsroom at https://ibn.fm/GXRFF

About MiningNewsWire

MNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from MiningNewsWire, text “BigHole” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, CA
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is powered by IBN

420 with CNW — Cannabis Banking Law Complicated by Conflicting Priorities, House Speaker Issues